Design: 421 archived cases of EC(1995EC( -2007 were reviewed and TMAs prepared as per established procedures. ERCC1 and RRM1 Immunofl uorescence stains were combined with Automated Quantitative Analysis to assess their expression. The average of triplicate core expression was used to determine high and low score cutoff points using log-rank test on overall survival(OS). Association between expression profi les and clinicopathological parameters was tested using Fisher's exact test. The independent prognostic value of ERCC1 and RRM1 was tested using Cox model adjusted for traditional prognostic factors. Results: 304(72%) type-I EC cases and 117(38%) type-II EC cases were identifi ed. Caucasian women had higher proportion of type-I tumors(p<0.001) while elderly women were more likely to have type-II tumors (p<0.001). ERCC1 and RRM1 expression was observed in 80% of tumors (336 cases  335 cases,respectively). Kaplan Meier curves showed statistically signifi cant difference in OS between low and high expression of ERCC1 and RRM1. OS remains signifi cantly different using Cox model adjusted for other covariates (age, race, histologic subtypes, lymph vascular invasion and stage) for the two markers. High ERCC1 scores were associated with increased OS when compared to low ERCC1 scores(p=0.007). In contrast, low RRM1 scores were associated with better OS compared to higher RRM1 scores (p=0.007). Log-rank test demonstrated that type-I tumors and advanced stage (FIGO III and IV) tumors could each be subdivided further into better and worse survival groups based on low and high RRM1 expression respectively(p<0.006). Similarly, lower stage (FIGO I and II) tumors with higher ERCC1expression are associated with better overall survival that those with lower ERCC1 expression(p=0.026).
Clincopathologic Correlation of Partial P16 Staining in
Oropharyngeal Squamous Cell Carcinoma S Barasch, P Mohindra, K Hennrick, G Hartig, P Harari, D Yang. University of WI, Madison, WI. Background: Human papilloma virus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) has highly favorable relative prognosis. p16 staining of tumor tissue by immunohistochemistry (IHC) is a surrogate marker for HPV infection and >75% p16+ cells or presence of >50% p16+ cells with >25% confl uence (groups of 10 cells) is suggested as a criteria for defi ning HPV+ status. However, clinical validation of these criteria or signifi cance of partial p16 staining has not been reported. Design: Archived tumor samples from 174 patients with OPSCC treated with curative intent from 1990-2010 were retrospectively stained for HPV-status either by IHC or in-situ hybridization. Of 81 samples stained with IHC, percentage of p16+ cells were categorized as 25% (36%), 26-75% (19%) or >75% (43%) patients. Percent confl uent cells were categorized as 25% (30%), 26-75% (7%) or >75% (63%) patients. Estimates of recurrence-free survival (RFS) and overall survival (OS) were calculated. Log-rank test was used for univariate analysis. Results: The median patient age was 58 years. Primary tumor site was base of tongue in 30 (37%) patients, tonsil in 42 (52%) and soft palate/pharyngeal wall in 9 (11%).
Using reported criteria, 48 (59%) patients were labeled p16+. With a median follow up of 3.4 years, 5-year OS and RFS for p16+ patients (80% and 76% respectively) were signifi cantly better than for p16-patients (39% each), p < 0.001. Based on percent p16+, 5-year RFS for  25%, 26-75% and >75% patient cohorts were 41%, 58% and 81% respectively, p < 0.001 [fi gure 1]. Based on percent confl uence, 5-year RFS for  25%, 26-75% or >75% patient cohorts were 37%, 26% and 77% respectively, p < 0.001 [fi gure 2]. Using a criteria of either >75% p16+ cells or >75% confl uence, 51 (63%) patients would be labeled as p16+ with 5-year RFS for the positive and negative cohorts of 77% and 34% respectively, p < 0.001.
Conclusions:
This report clinically validates the prognostic signifi cance of graded p16 staining and percent confl uence as surrogate markers of HPV status. In cases where percentage of cells stained is less than 75%, increasing the confl uence criteria for HPV positivity from >25% to >75% may improve patient dichotomization. Background: Chondrosarcomas (CS) arising in the head and neck are rare, comprising 15% of all CS. Defi nitive management guidelines for this anatomic subset do not exist. This study was undertaken to examine the histopathologic features, prognosis and current treatment of this rare entity. Design: A 25-year retrospective review at two separate institutions yielded 30 cases with slides available for review. Clinical and radiologic characteristics were retrieved via the electronic medical record. HE stained slides for each case were reviewed by a specialist in bone and soft tissue pathology for histologic features including grade, myxoid change, mitotic count, bone invasion, and margin status. Clinical characteristics for each patient included demographics, radiologic features, presenting symptoms, smoking or radiation history, treatment and outcome. Results: Demographics were as follows: M:F ratio of 1:1 with a mean age of 47 years (range 10-85). Eight patients were smokers, and 2 had a history of radiation therapy to the affected site. The primary tumor sites were: 11 skull base, 6 clival, 5 larynx, 6 nasal, and 2 maxilla. Tumor size averaged 4.5 cm (range 1-14). 14 (47%) cases were grade 1, 12 (40%) grade 2, and 4 (13%) grade 3. 15 CS contained myxoid stroma. Mitotic counts≥1/10 HPF were found only in grade 3 CS (3 cases). 20 tumors infi ltrated bone. Seven patients underwent biopsy only (including one FNA), 10 marginal excision, 3 wide excision and 10 composite resections. Follow-up was available for 23 patients (mean 35 months, range 10-176). 12 (40%) patients were alive with no evidence of disease, of whom 7 had surgery alone and 5 had surgery and radiation (6 grade 1, 5 grade 2, 1 grade 3). Nine (30%) patients were alive with either stable residual disease or indolent local recurrence, all of whom underwent surgery and radiation (6 grade 1, 3 grade 2). One patient died of other causes with no evidence of disease. No patients developed metastases. Only one patient (with a grade 3 nasal CS) died of disease. Conclusions: CS of the head and neck have a favorable prognosis following either surgery alone or in combination with radiation. Of those patients treated only with surgery, none developed recurrence. One patient with grade 3 CS died of locally aggressive disease. These findings support the alternate designation "atypical cartilaginous tumor" (for grade 1 CS), as recently suggested by the WHO.
Glandular Odontogenic Cysts Consistently Lack the MAML2 Rearrangements That Are Frequently Found in Central Mucoepidermoid
Carcinomas JA Bishop, R Yonescu, D Batista, WH Westra. The Johns Hopkins Medical Institutions, Baltimore, MD. Background: Glandular odontogenic cyst (GOC) is a rare cyst of the gnathic bones characterized by squamous and glandular differentiation. The histopathologic features of GOC overlap with central mucoepidermoid carcinoma (MEC), suggesting that GOC could be a precursor to or low-grade form of central MEC. Differentiating the two tumors may be diffi cult or impossible, particularly on a limited biopsy. MAML2 rearrangements have been recently found to be specifi c for MEC, even those arising in the jaws. An analysis of MAML2 in GOCs could help clarify its relationship with central MEC. Design: Tissue blocks from 21 GOCs and 5 central MECs were retrieved from the surgical pathology archives of The Johns Hopkins Hospital. The slides were rereviewed to confi rm the diagnoses. Each MEC exhibited solid areas and clear-cut stromal invasion. In addition, 4 of the MECs demonstrated cystic areas that were histologically similar to GOC. Break-apart fl uorescence in situ hybridization (FISH) for MAML2 was performed. For the MECs, analysis was performed on both the solid and GOC-like cystic components. Results: MAML2 rearrangements were identifi ed in all 5 of the MECs, but in none of the 21 GOCs (100% vs 0%; p <.0001, Fisher's Exact). In the MECs, the rearrangement was present in both the solid and GOC-like cystic areas. Conclusions: While central MECs consistently harbor the MAML2 rearrangement, even in those low grade cystic areas that resemble a pre-existing GOC, true GOCs do not. Accordingly, GOC does not appear to represent an early or low grade form of central MEC, but rather an unrelated lesion. For diffi cult cystic lesions of the gnathic bones where the disctinction of MEC and GOC is critical, MAML2 FISH may be useful in aiding this distinction. Background: High risk human papillomavirus (HPV) is now fi rmly established as an important cause of a subset of head and neck squamous cell carcinomas. Recent studies using polymerase chain reaction (PCR) methods have also implicated HPV as a cause of mucoepidermoid carcinoma (MEC) -a tumor of salivary gland origin that frequently harbors the MAML2 translocation. We performed RNA in situ hybridization for E6/E7 mRNA transcripts on a large group of genetically characterized MECs to establish the prevalence of transcriptionally active HPV, and to determine whether transcriptionally active HPV obviates the need for the MAML2 translocation. Design: A tissue microarray (TMA) containing 92 mucoepidermoid carcinomas was constructed. Break-apart fl uorescence in situ hybridization for MAML2 was performed on the TMA to determine the translocation status of each individual tumor. HPV testing was also performed using RNA in situ hybridization targeting HPV mRNA E6/E7 transcripts (a cocktail of 18 high risk HPV genotypes including 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82) . Results: MAML2 FISH was successfully performed on 75 MECs, and 56 (75%) were positive for the rearrangement. In the presence of readily identifi able signals in HPVpositive controls run in parallel, none of the 92 (0%) MECs were positive for high risk HPV by RNA in situ hybridization.
Mucoepidermoid Carcinoma Does Not Harbor Transcriptionally

Conclusions:
The complete absence of transcriptionally active HPV suggests that HPV does not play any substitutional role for the MAML2 translocation or any role whatsoever in the development of MECs. Background: PAX2 and PAX8 are transcription factors involved in embryogenesis that have been utilized as immunohistochemical indicators of tumor origin. Specifi cally, PAX2 is a marker of neoplasms of renal and Müllerian origin, while PAX8 is expressed by renal, Müllerian, and thyroid tumors. While studies examining these transcription factors in a variety of tumors have been published, data regarding their expression in salivary gland neoplasms are limited. The goal of this study was to assess expression of PAX2 and PAX8 in a large cohort of salivary gland tumors. Design: Tissue microarrays (TMAs) containing samples of 442 benign and malignant salivary neoplasms and 68 normal salivary glands were stained using antibodies against PAX2 and PAX8. Staining was scored on the basis of nuclear positivity as follows: 1+ for 1-10% positive nuclei, 2+ for 10-50% positive nuclei, and 3+ for≥51% positive nuclei. Results: Positive staining with PAX2 among evaluable samples was as follows: 0/131 mucoepidermoid carcinomas (MECs), 1/32 acinic cell carcinomas (ACCs), 0/37 adenoid cystic carcinomas (AdCCs), 0/47 salivary duct carcinomas (SDCs), 0/18 polymorphous low-grade adenocarcinomas (PLGAs), 0/6 myoepithelial carcinomas, 0/6 epithelial-myoepithelial carcinomas (EMCs), 0/4 basal cell adenocarcinomas, 0/16 Warthin tumors, 0/19 pleomorphic adenomas (PAs), 0/7 myoepitheliomas, 0/18 basal cell adenomas, 1/53 oncocytomas, and 0/19 canalicular adenomas (CAs). Both the ACC and oncocytoma with positive staining had focal, weak reactivity (1+). Results with PAX8 were: 0/131 MECs, 0/33 ACCs, 0/39 AdCCs, 0/46 SDCs, 0/18 PLGAs, 0/6 myoepithelial carcinomas, 0/6 EMCs, 0/4 basal cell adenocarcinomas, 0/16 Warthin tumors, 0/19 PAs, 0/7 myoepitheliomas, 0/18 basal cell adenomas, 0/53 oncocytomas, and 0/19 CAs. Among normal salivary gland samples, there was evaluable tissue from 49 parotid glands, 15 minor salivary glands, three submandibular glands, and one sublingual gland, all of which were negative with both PAX2 and PAX8. Conclusions: PAX2 expression is not seen in normal salivary glands and is very rare in salivary gland neoplasms, in which positivity appears to be focal and weak. No normal salivary gland or salivary gland tumor demonstrated expression of PAX8 in our cohort. In conjunction with previously published data, these results suggest PAX2 and PAX8 immunohistochemical stains would be useful in distinguishing salivary gland neoplasms from metastasis of morphologically similar tumors such as renal or thyroid carcinomas.
Evaluation of PAX2 and PAX8 Expression in Salivary Gland
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Sinonasal Carcinomas: A 10-Year Review in a Tertiary Care Center JM Choi, D Kokh, AP Burke, KC Tuttle, JC Papadimitriou. University of Maryland Medical Center, Baltimore, MD. Background: Sinonasal carcinomas include squamous cell carcinoma (SCC), adenocarcinoma, sinonasal undifferentiated carcinoma (SNUC), and salivary gland type tumors which include adenoid cystic carcinoma (ACC), mucoepidermoid carcinoma (MEC), and, very rarely, acinic cell carcinoma. They are all uncommon neoplasms, accounting for 3-5% of upper respiratory tract neoplasms. There are only a few studies comparing stage, age and localization among different histologic subsets of sinonasal carcinomas. Design: We retrospectively studied 10 years of resections of sinonasal carcinomas and reviewed age, gender, histologic type, and stage. Tumors were classifi ed by histologic type. For non-keratinizing carcinomas that were diffi cult to categorize, immunohistochemical stains were used with SCC as CK5/6 or p63 positive and SNUC as CK5/6 and p63 negative, pan-cytokeratin positive, and negative for endocrine markers. Results: 161 resections of carcinomas involving the sinonasal tract were performed, with a slight male predominance (54%). There were 58 primary sinonasal carcinomas: 23 (14%) originated in the maxillary sinus cavity, 25 (15%) in the nasal cavity, and 10 (6%) in the ethmoid or frontal sinuses. The remaining 103 cases were primary carcinomas from the oral cavity (91), nasopharynx (6), and skin (6) with direct extension into the sinonasal tract. Patients with primary carcinomas arising in the nasal cavity or paranasal sinuses were signifi cantly younger than those extending from the outside the sinonasal tract (p=.001). Tumors arising in the nasal cavity were less likely to present at an advanced stage than those arising in the paranasal sinuses (p=.001). 75% of tumors extending from outside the sinonasal tract were keratinizing squamous cell carcinomas, and the majority of the remainder were non-keratinizing squamous cell carcinomas or salivary gland type tumors. Primary carcinomas of the paranasal sinuses were more diverse: 31% non-keratinizing SCC, 29% keratinizing SCC, 15% SNUC, 11% salivary gland type tumors, 7% non-keratinizing SCC arising from Schneiderian papillomas, and 7% adenocarcinomas NOS. There were no cases of small cell/neuroendocrine carcinomas. Conclusions: Sinonasal carcinomas are uncommon neoplasms of the nasal cavity and paranasal sinuses. Sinonasal carcinomas can be asymptomatic and often present at late stages. We found that primary carcinomas of the paranasal sinuses present at a later stage than primary carcinomas of the nasal cavity. These patients also tend to be younger than those with primary carcinomas with direct extension into the sinonasal tract.
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Keratocystoma: Three Cases of a Rare Parotid Gland Tumor A Cole, J Hunt, R Cox. UAMS, Little Rock, AR. Background: Keratocystoma is a rare tumor of the parotid gland consisting of multiple cystic spaces lined by keratinizing squamous epithelium lacking atypia. Since the original description of the lesion as a choristoma of the parotid gland by Seibert et al. in 1999, few additional cases of keratocystoma have been identifi ed within the literature. We describe a series of three cases of this unusual tumor of the parotid gland. Design: The consultation fi les of one of the authors were reviewed from 2009 to present for salivary gland lesions having the previously described histologic features of keratocystoma. These tumors were composed of multicystic spaces arranged in a non-lobular architecture and lined by stratifi ed squamous epithelium. The squamous epithelium must be lacking atypia and have an absent or discontinous, attenuated granular layer. Results: Three cases of keratocystoma were identifi ed. Clinically, all patients were female with an age range of 40-57 (mean: 49 years). The parotid gland was involved in all cases (right: 2 cases, left: 1 case). Grossly, the lesions ranged from 1.7-3.0 cm (mean: 2.5 cm) in size and were described as cystic masses containing soft, tan material. Histologically, the cases were composed of multiple cysts lined with keratinizing squamous epithelium with variable degrees of hyperkeratosis. In one case, no granular cell layer was present in any of the squamous epithelial lining, while in two cases a minority of the cysts were lined with squamous epithelium having an attenuated, discontinous granular cell layer. No atypia was identifi ed within the squamous epithelium. In two of the cases, rare to occasional interspersed solid nests of squamous epithelium were present. The smallest lesion was composed of cystic structures only. In one case, parotid ductal epithelium was identifi ed transitioning into the stratifi ed squamous epithelial layer. All cases had a random, irregular distribution of the cysts and solid nests, with no lobular architecture apparent. The surrounding stroma appeared fi brotic with varying degrees of chronic infl ammation present. In two cases, granulomatous infl ammation was present, likely in response to keratinaceous debris. No skin appendages were identifi ed within the adjacent stroma. Conclusions: We describe three cases of keratocystoma, a rare parotid gland tumor that can mimic both benign lesions, such as dermoid cysts, and malignant lesions. To our knowledge, the current study presents the largest series of cases thus far described. Knowledge of this unusual, benign lesion is important, as it can be mistaken for malignant lesions such as metastatic squamous cell carcinoma or mucoepidermoid carcinoma.
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FANCD2 Expression Is Increased in HPV16+ Oropharyngeal Carcinomas X Cui, T Isayeva, M Brandwein-Gensler. University of Alabama at Birmingham, Birmingham, AL. Background: The Fanconi Anemia pathway (FA or FANC/BRCA)is activated in response to chromosomal replicative stress. HPV16-E7 can activate the FA pathway, as E7 promotes unscheduled S-phase entry via cyclin deregulation. In turn, elevated FANC-D2 can limit HPV replication. Here, we investigate FANCD1/FANCD2 protein expression in oropharyngeal carcinoma (OPC) typed for HPV16 and HPV18. Design: Archival specimens from 99 OPC patients were previously typed for transcriptionally active HPV16 and HPV18 by reverse transcription, and real time nested PCR using type specifi c E6 and E7 primers. FANCD1 and FANCD2 were assessed by IHC on whole slides; staining quantifi ed by H-score (range 0 -12) . A representative image of positive (H=12) and negative (H=0) staining is shown.
Results:
Transcriptionally active HPV16/18 was present in 64% of OPC (46% HPV16+, 7% HPV18+, and 7% HPV16/18+). High H-score was common for FANCD1 and did not correlate with HPV status. A trend is seen with high FANCD2 (H-score≥ 6/12) and HPV16 (p = 0.088, Fischer's exact test); no association was seen with HPV18. Time to overall survival (OS) was increased with high FANCD2 (p = 0.056); protective trends were seen for high FANCD2 and disease specifi c survival (p = 0.093) and disease progression (p = 0.395). Subgroup analysis by treatment (chemoradiation vs surgery +/-adjuvant therapy) suggests that this effect is not associated with improved response to chemoradiation. Stratifying for HPV16 and FANCD2 demonstrates that OPC patients with HPV16+ low FANCD2 (green line, Fig 2) have poorer OS than high FANCD2 OPC, regardless of HPV16 status (p = 0.0049).
Conclusions:
Upregulation of FANCD2 is associated with HPV16+ OPC. As this protein inhibits HPV replication, it may be an important modulator of outcome for patients with HPV16-mediated OPC. Further studies are necessary.
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HPV L1 in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16, HPV ISH, and Outcome DG Davis, DR Braxton, N Fatima, ST Momin, C Cynthia. Emory University, Atlanta, GA. Background: The importance of human papilloma virus (HPV) in the development of oropharyngeal squamous cell carcinoma (OSCC) has been increasingly recognized. Numerous studies have demonstrated the improved prognostic signifi cance of HPV positivity in OSCC. HPV L1 immunohistochemistry (IHC) uses a monoclonal antibody specifi c for the L1 viral capsid protein produced in the late phase of viral replication. The purpose of this study is to evaluate the effectiveness of HPV L1 IHC for the diagnosis of HPV in OSCC and to compare it to p16 IHC and HPV in-situ hybridization (ISH). HPV L1 was also correlated with overall survival. Design: 74 cases of OSCC (52 surgical specimens, 22 fi ne needle aspirations [FNA] of cervical lymph node metasteses) were identifi ed; HPV L1 (Lifespan Biosciences) IHC, p16 IHC, and HPV ISH were performed on 5 micron, formalin-fi xed, paraffi n-embedded sections. HPV L1 and p16 exhibited nuclear and cytoplasmic staining, while HPV ISH staining was noted in nuclei in a dot-like pattern. HPV ISH was used as the gold standard. 
Conclusions:
The majority of OSCC's studied were of advanced clinical stage and expressed HPV L1 primarily in the dysplastic mucosa adjacent to the invasive carcinoma. Our study demonstrated that HPV L1 IHC is a sensitive, but not specifi c, marker of HPV and is unlikely to be a useful adjunct to p16 IHC or HPV ISH in the evaluation of OSCC.
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Sirtuin-3 Immunohistochemical Expression in Oropharyngeal Squamous Cell Carcinoma: Correlation with Outcome DG Davis, DR Braxton, N Fatima, BC Willis, MT Siddiqui, C Cohen. Emory University, Atlanta, GA. Background: Recent studies reveal the importance of the sirtuin family of proteins. They function as tumor suppressors via their ability to reprogram mitochondrial metabolism during nutrient stress and through control of reactive oxygen species. A specifi c mitochondrial sirtuin, sirtuin-3 (SIRT3), has been investigated in oropharyngeal squamous cell carcinoma (OSCC) and is found to be up-regulated relative to benign squamous mucosa. We studied SIRT3 in relation to overall survival in OSCC. Design: 69 OSCC's (47 surgical specimens and 22 FNA's of cervical nodes with metasteses) were identifi ed. SIRT-3 immunohistochemistry was performed on 5m, formalin-fi xed, paraffi n-embedded tissue sections. Cytoplasmic staining of SIRT3 was assessed as 0-3+ intensity (relative to controls of benign squamous mucosa) and the percentage of positive cells was recorded. Positive SIRT3 expression was correlated with overall survival. Results: 36 (61%) of 69 total cases (30 surgical and 6 cytology specimens), stained positively for SIRT3 with a range of 1-3+ intensity. Positive staining was observed predominantly in poorly differentiated regions of invasive carcinoma. Minimal to no staining was seen in normal controls of oropharyngeal squamous mucosa and in normal mucosa adjacent to carcinoma. Positive SIRT3 IHC did not signifi cantly affect overall survival.
Conclusions: SIRT3 expression did not affect overall survival. However, overexpression of SIRT3 in the majority of the OSCC's, particularly in more poorly differentiated tumors, confi rms the fi ndings of prior studies and reveals that SIRT3 alterations may be a factor in the molecular pathogenesis of OSCC. Recent fi ndings of mutations in the active site of the enzyme in several cell lines isolated from OSCC raise the possibility that, while over-expressed, the enzyme may be functionally impaired. This may explain the observed correlation with SIRT3 expression in poorly differentiated foci of carcinoma. I Fonseca, M Fox, K Wani, K Aldape, D Bell . MD Anderson Cancer Center, Houston, TX; Instituto Português de Oncologia Francisco Gentil, Lisabon, Portugal. Background: Diverse microarray/ sequencing technologies were used to characterise molecular changes in malignant epithelial cells in salivary neoplasms. Such gene expression studies to identify markers and targets in tumour cells are compromised by cellular heterogeneity of these tumours and by lack of appropriate counterparts representing normal salivary. Design: 17 primary salivary epithelial-myoepithelial carcinomas and 6 normal salivary counterparts were microdisected from paraffi n embedded tissue. Pools of RNA from highly enriched preparations of these cell types were subjected to expression profi ling using a whole transcriptome shotgun sequencing experiment. Results: Statistical correlation analysis of the resulting data allowed continuing with a comparative analysis of 6 normal samples versus 13 neoplastic samples, 4 neoplastic samples were excluded. Using strict /conservative criteria 220 differentially expressed transcripts were found, with 36% up-and 64% downregulated. The transcripts were annotated using NCBI Entrez Gene, and computational analyzed with the Ingenuity Pathway Analysis program. From these signifi cantly changed expressions the analysis fi nds 26 cancer-related (ACAT1, ARPC1A, ATP5J, CANX, DDX39B, DDOST, EXT1, FGFR1, GOLPH3, MAGT1, MAPK8IP3, MAT2A, MMADHC, P4HB, PDK4, RHOA, SCARB2, SDHB, SDHD, SEC63, SSR1, SSR3, TM9SF2, TMED2, TRAM1, ZMPSTE24) and 16 transcripts which are related to mitochondrial dysfunction (ATP5A1, ATP5F1, ATP5J, COX7B, COX7C, MT-ND5, NCSTN, NDUFA4, NDUFA5, NDUFAB1, NDUFB11, NDUFV2, PDHA1, PRDX3, SDHB, SDHD), overlapping with 3 cancer-genes. These fi ndings are well supported by existing literature about this cancer. From other strongly differentially expressed transcripts of microRNAs and certain genes the biological functions and their role in this cancer are still unknown. Conclusions: These 220 differentially expressed genes and microRNAs provide for the fi rst time, a suffi cient large set to specifi cally defi ne epithelial-myoepithelial carcinoma, with basis for the identifi cation of novel and potentially important targets for diagnosis, prognosis and therapy in this cancer. Clinical pathological validation of a small number of genes is currently ongoing on tissue microarrays. These data will form the basis for understanding not only cell fate determination and cellular homeostasis in the normal salivary epithelium but also the contribution of different salivary epithelial cell types to the etiology and molecular pathology of salivary disease.
Whole Genome Expression Profiling of Epithelial-Myoepithelial Carcinoma of Salivary Glands
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Rab25 Expression as a Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma AE Foster, R Uppaluri, A Winkler, E Duncavage, J Lewis. Washington University, St. Louis, MO. Background: Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OSCC) has a quite favorable prognosis. However, a signifi cant minority of patients suffer disease recurrence, particularly as distant metastases. Hence, discovering new genes that may contribute to tumor aggressiveness could potentially lead to more personalized treatment. We previously identifi ed Rab25 as selectively mutated in patients with distant metastases in prior genomic studies, and other literature has suggested that it functions as a tumor suppressor. Design: Immunohistochemistry was performed for Rab25 on a tissue microarray cohort of OSCC cases with known clinical follow-up and p16 status. p16 positivity was defi ned as≥50% immunostaining. Rab25 staining was assessed visually for percentage of tumor cells with cytoplasmic expression and stratifi ed into quartiles. For analysis, this was dichotomized as >75% (4+) vs all others. Cases with Rab25 nuclear expression were read as positive or negative. Results were compared with clinicopathologic features and patient outcomes. Results: 136 p16-positive OSCC were present on the array, of which 113 (83%) had >75% Rab25 expression. Low Rab25 expression (<75%) correlated signifi cantly with development of distant metastases (p=0.02), with death from any cause (p=0.003), and had lower 5-year survival rates when compared with high Rab25 expression (55% vs 85%; p=0.01). However, there was no statistically signifi cant difference when looking at death from disease (p=0.07). Low Rab25 expression was statistically signifi cantly correlated with higher T-stage (p=0.02) and defi nitive vs surgical management (p = 0.006), but no signifi cant difference was seen by Rab25 for N-stage, sex, race, or histological tumor type. Nuclear expression was seen in only 5 patients (3.7%), 1 (20%) of whom developed distant metastasis vs. 9 of 130 (6.9%) of the nuclear negative patients. However, the numbers are too small for meaningful analysis.
Conclusions:
The majority of HPV-related OSCC cases show extensive tumor cell expression of Rab25. Reduced Rab25 expression correlates with poorer outcomes, suggesting it acts as a tumor suppressor, but this association is modest. Nuclear Rab25 expression is rare but may be a refl ection of protein mutation correlating with tumor aggressiveness.
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Analysis and Significance of c-MET Expression in Adenoid Cystic Carcinoma of Salivary Gland MD Fox, D Roberts, RS Weber, AK El-Naggar, D Bell . MD Anderson Cancer Center, Houston, TX. Background: Increased copy number gain and amplifi cation of c-MET, the cell surface receptor for hepatocyte growth factor (HGF), has been shown to enhance tumor growth and invasiveness and promote metastasis in certain tumor types. The relevance of its expression in adenoid cystic carcinoma (ACC) of salivary gland origin was fi rst described in 2003 in a study published by Suzuki, et. al. Although their fi ndings were novel, its small case number limited the impact of the study. In the present investigation, we evaluated the expression of c-MET in a large cohort of salivary ACCs and examined its clinicopathologic implications. Design: Formalin-fixed, paraffin embedded tissue blocks of 199 cases of ACC of salivary gland origin, diagnosed at UTMDACC between 1986 and 2006, were retrospectively reviewed. Tissue microarray's from each case were constructed for immunohistochemical analysis of anti-c-Met antibodies. The results were independently evaluated by two pathologists. Results: Expression of c-MET protein was seen in approximately half of the cases that were evaluated. There was no correlation between c-MET expression and overall patient survival at three and fi ve years. Additionally, c-MET expression was not associated with any particular histologic type of ACC (cribriform, tubular, solid) and failed to demonstrate a relationship with tumor invasiveness as was previously considered. Conclusions: Our fi ndings contradict the purposed theory that c-MET expression, in ACC of the salivary gland, imparts a more aggressive clinical outcome. There appears to be no relevance for targeted therapy against c-MET protein in this sub-group of salivary gland tumors.
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Targeted Next-Generation Sequencing of Salivary Gland HighGrade Neuroendocrine Carcinomas B Goyal, EJ Duncavage, JS Lewis, Jr., RD Chernock. Washington University School of Medicine, St. Louis, MO. Background: High-grade neuroendocrine carcinoma (NEC) of the salivary gland is a rare aggressive malignancy that usually arises in the parotid, has a male predominance, and a peak incidence in the 6th-7th decade of life. The majority express cytokeratin 20 (CK20) and are referred to as "Merkel cell type" because CK20 is also expressed by histologically similar cutaneous high-grade neuroendocrine (Merkel cell) carcinomas (MCC). Up to 80% of MCCs harbor the Merkel cell polyomavirus (MCPyV), which is not found in high-grade salivary gland NECs. Whole exome sequencing of MCCs show MCPyV-negative, but not -positive, cases to consistently have nonsense mutations in RB1. Besides the absence of MPCyV, little is known about the genetic landscape of salivary gland high-grade NECs. Design: 4 cases of primary salivary gland high-grade NEC were retrospectively selected from our archives after excluding the possibility of metastasis from a skin or other primary site. 1 ug of DNA, extracted from formalin-fi xed, paraffi n-embedded tissue blocks using standard methods, was used to construct Illumina paired-end libraries. These libraries were then captured using a panel of 40 genes that are known to be clinically actionable in cancer and sequenced using 101bp paired-end reads at 815x coverage. Sequence data was analyzed using our institution's existing analysis pipeline. Signifi cant variants were determined by looking for recurrently mutated genes and comparing data to publically available databases of somatic mutations (COSMIC, TCGA). PROVEAN and SIFT software was used to predict function of the signifi cant variants. Results: Next generation sequencing of a targeted gene panel identifi ed an average of 316 (range 256-341) single nucleotide variants (SNV) per case. 2.1% of these SNVs resulted in coding region changes not reported in dbSNP. 9 somatic mutations were identifi ed in 5 genes, of which 8 were considered to alter structure or be deleterious in 4 genes by PROVEAN and SIFT software (Table1). FNA (1999 FNA ( -2012 of which 303 primary salivary epithelial lesions with corresponding surgical follow-up within 6 months were available for review. Adequacy was defi ned as at least 4 high power (400x) fi elds with the majority of the fi eld consisting of epithelial cells. Cases were placed into categories based on cytonuclear features (cellularity, stroma, cytoplasmic tinctorial quality, nuclear grade and mitoses). Resection specimens were reviewed. Both risk of malignancy and risk of high grade malignancy were calculated for each category. Results: Initial results for 98 aspirates (1999) (2000) (2001) (2002) (2003) (2004) (2005) show a surprising 39% unsatisfactory rate (11% of which were cyst contents). Risk stratifi cation categories are shown in the We characterized a large cohort of salivary duct carcinomas (SDC) by conventional clinicopathologic parameters and genetic alterations. Specifi cally, we assessed the potential phosphoinositide 3-kinase (PI3K) pathway activation due to p110 catalytic subunit of phosphoinositide 3-kinase (PIK3CA) mutation/amplifi cation, AKT1 mutations, or loss of phosphatase and tensin homolog (PTEN). Androgen receptor (AR) expression, HER2 amplifi cation, and the relationship between PLAG1 and HMGA2 rearrangements and PIK3CA mutations were evaluated. Design: Clinicopathologic parameters (e.g., tumor size, TNM stage, precursor lesions) of 171 cases of SDC diagnosed in 5 centers were correlated with overall and disease-free survival. Potential PI3K pathway activation was determined by testing for PIK3CA mutations (Sanger sequencing or SNaPshot PCR) and AKT1 (Sanger sequencing) mutations, PIK3CA amplifi cation (FISH) and/or loss of PTEN (FISH). PLAG1 and HMGA2 status and HER2 amplifi cation were also tested by FISH. AR status was determined by immunohistochemistry. Results: AR was positive in 82% (83/101). HER2 was amplifi ed in 43% (10/23). PIK3CA mutations were detected in 32% (14/58): p.E545K (n=4), p.E542K (n=3), and p.H1047R (n=7). PIK3CA amplifi cation was not detected (0/25) . PTEN loss was found in 36% (9/25): homozygous deletion (n=3), chromosome 10 monosomy (n=4), and hemizygous deletion (n=2). No mutations were detected in AKT1 (0/15). Overall, 36.2% (21/58) SDCs showed changes associated with PI3K pathway activation. Currently, we are exploring the relationship between PIK3CA mutations and previously reported PLAG1 and HMGA2 status (rearranged in 49%, 18/37). Conclusions: AR expression, HER2 amplifi cation, and potential PI3K pathway activation are common targetable molecular alterations in SDC. Relationships among clinicopathologic and genetic events may uncover the sequence of molecular changes involved in SDC pathogenesis, elucidate a rational approach to personalized molecular testing, and suggest additional therapeutic options.
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Detection of Human Papilloma Virus in Non-Neoplastic Tissue of Patients with Primary Oropharyngeal Carcinomas: Does a Field Effect Exist?
JC Hernandez-Prera, DY Zhang, EM Genden, JA Longtine, EG Demicco. Icahn School of Medicine at Mount Sinai, New York, NY. Background: The presence of a fi eld effect in head and neck cancer has important clinical signifi cance. Little information exists about this phenomenon in patients with human papillomavirus oropharyngeal squamous cell carcinoma (HPV-OPSCC). The aim of this study is to evaluate for HPV status in non-neoplastic tissue from patients with HPV-OPSCC. Design: Ipsilateral and contralateral tonsillar tissue from patients with HPV-OPSCC was screened to identify blocks with non-tumor, non-dysplastic tonsillar epithelium. Control HE slides were carefully evaluated for focal neoplasia. DNA was extracted and assessed for amplifi cation of the L1 region of the HPV genome by real time PCR, using -actin amplifi cation as a control for DNA quality. HPV genotype was determined by melting curve analysis. Immunohistochemistry (IHC) for p16 protein was performed. Follow-up was collected form clinical charts. Results: Specimens included 25 ipsilateral and 5 contralateral normal tonsillar sections from 25 patients. Tumor foci were identifi ed on the control HE in 6 cases (3 in situ and 3 invasive carcinoma). Of the remaining ipsilateral uninvolved tonsils, 74% (14/19) were negative for HPV while 26% (5/19) were positive for HPV 16. All contralateral tonsils were negative for HPV. -actin amplifi cation was adequate in all cases. Immunohistochemical studies for p16 stain demonstrated strong positivity in neoplastic cells, and patchy weak p16 positivity in adjacent normal epithelium and contralateral tonsils. There was no correlation between the HPV status and p16 staining in histologically normal epithelium. No recurrence was reported after a mean follow-up of 14.7 months. Conclusions: HPV DNA was not detected in non-neoplastic tissue in the majority of our HPV-OPSCC cases (76% of adjacent normal tissue; 100% of contralateral tonsils). These fi ndings suggest that HPV in patients with HPV-OPSCC does not generally establish widespread persistent infection in non-neoplastic tonsilar tissue. Thus, fi eld effect is less of a concern for HPV-OPSCC than in smoking-related keratinizing oral squamous cell carcinoma. Design: Institutional pathology records were searched for HN tumors using the terms "CC", "CC features", and "CC rich". All identifi ed cases were reviewed and subjected to fl uorescence in situ hybridization (FISH) on paraffi n sections using a commercially available EWSR1 dual-color break-apart probe (Abbott, Des Plains, Il) localized to chromosome 22 band q12. FISH results were scored blindly from morphologic diagnosis. Results: Twenty eight cases with prominent CC component were retrieved, comprising 18 biopsies and 10 resections. Diagnoses included 10 HCCC (9 primary and 1 lung metastasis); 2 OCCC; 4 mucoepidermoid carcinoma; 3 poorly differentiated carcinoma NOS; 1 adenocarcinoma NOS; 1 CC oncocytic hyperplasia; 1 myoepithelial carcinoma; 1 squamous cell carcinoma; and 5 metastatic renal cell carcinoma. FISH was technically adequate in 24 cases. EWSR1 rearrangements were detected in 46% (11/24). Positive cases included 89 % (8/9) of HCCC and 100% (2/2) of OCCC. A case originally diagnosed as squamous cell carcinoma with CC features showed EWSR1 rearrangements and was reclassifi ed as HCCC. All other tumors were negative for rearrangement. Conclusions: FISH testing using dual color EWSR1 probe is a useful marker to distinguish HCCC and OCCC from other CC lesions of the head and neck, both in primary and metastatic lesions. Moreover, our fi ndings validate the practicality of this approach in the diagnosis of small biopsies. The application of this approach will lead to more accurate classifi cation of tumors with overlapping histologic features and improved prognostication and management decisions.
EWSR1 Rearrangement Is Diagnostically Useful to Differentiate Clear Cell Lesions of the Head and Neck
1319 Immunohistochemistry for -Catenin in Fibro-Osseous Lesions of the Craniofacial Skeleton AE Horvai, R Jordan. UCSF, San Francisco, CA. Background: The canonical Wnt/-catenin pathway is involved in the formation of the craniofacial skeleton and head and neck tissues. Aberrant nuclear localization of -catenin was recently described in a subset of odontogenic tumors suggesting analogous growth promoting mechanisms to those of desmoid fi bromatosis and colorectal carcinoma. Fibro-osseous lesions of the craniofacial skeleton are a group of neoplastic, self-limited, mesenchymal proliferations in which -catenin status is unknown. This study aimed to characterize the prevalence of aberrant nuclear localization of b-catenin in a large series of fi bro-osseous lesions of the craniofacial bones. Design: 172 fibro-osseous tumors were identified from routine pathology and consultation fi les of the authors. The diagnoses were confi rmed by review of histologic, radiographic and clinical variables. Immunostaining was performed on formalin-fi xed paraffi n-embedded representative sections using the BD Biosciences (clone 14B) -catenin antibody (1:400). Slides were scored for nuclear staining, independently by AEH and RJ, blinded to the diagnoses, with consensus reached on all discrepant results. Results: The series consisted of 172 tumors from 160 patients (45 male, 115 female; average age 32, range 2-69). No patients had documented familial adenomatous polyposis syndrome. Nuclear -catenin immunostaining was detected in 34 (20%) tumors overall with no correlation between age, gender, or tissue decalcifi cation and nuclear positivity (p=0.2, 0.17, 0.12, respectively). Distribution of staining by tumor type is shown in Table 1 . Absent nuclear -catenin in fi brous dysplasia was the only diagnostically signifi cant fi nding (p=0.0034). Conclusions: Nuclear staining for -catenin is relatively common among fi broosseous lesions of the craniofacial skeleton implicating the Wnt/-catenin pathway in the pathogenesis of a subset of these lesions. With the exception of fi brous dysplasia, the individual categories of fi bro-osseous lesions show similar frequency of nuclear -catenin positivity. Thus, the fi nding of nuclear -catenin has limited utility in discriminating among the other entities. The molecular mechanisms underlying nuclear -catenin accumulation in the positive tumors is under investigation. were identifi ed and compared with head and neck plasmacytomas from our archives. Clinical information, histologic, immunohistochemical (IHC) and molecular fi ndings were reviewed. Presence and extent of acute infl ammation, admixed lymphocytes, plasmacytic bi-, tri or multinucleation, anisocytosis, hyperchromasia, exocytosis, mitoses, conspicuous nucleoli, Russell and Dutcher bodies was semi-quantitatively assessed.
Oral Plasmacytoses and Head and Neck
Results: 15 PCL samples (7 gingiva, 3 buccal, 2 hard palate, 1 tongue, 2 periodontal tissue) from 14 patients, 5 male and 9 female, mean age 60 (range 46-83) and 7 PCN samples (2 laryngeal, 3 oral, 1 sinonasal, 1 nasopharyngeal) from 6 patients, 5 male and 1 female, mean age 58.5 (range 39-82) were reviewed. 6 PCL patients had history of multiple myeloma, 4 of SCC, and 1 of lichen planus. 11 had single and 3 had multiple lesions. Clinical fi ndings included leukoplakia, erythroplakia, oral lichen planus, verrucoid lesions, osteonecrosis, and periodontal cysts. Squamous mucosa was hyperplastic in 9 and dysplastic in 3. All PCL had Plasma cells (PCs) with variable degree of atypia, anisocytosis (100%), hyperchromasia (53%), binucleation (93%), Russell (87%) and Dutcher (33%) bodies but none showed prominent nucleoli, tri-and multinucleation, mitoses;the latter were seen in 57%, 71%, 43%, and 43% of PCN, respectively. Admixed lymphocytes, Russell bodies, exocytosis and acute infl ammation were less common in PCN. The data regarding the signifi cance of lymphatic vessel density (LVD) in advanced head and neck cancer is inconsistent. The goal of our study was to examine the relationship between LVD, tumor staging, and lymph node status in advanced laryngeal squamous cell carcinoma (SCC). Design: A total of 55 laryngectomy specimens from previously untreated patients with advanced laryngeal SCC were included. Selected blocks from formalin-fi xed paraffi n embedded specimens were sectioned and stained with hematoxylin-eosin and immunostained with D2-40, specifi c marker for lymphatic endothelial cells. Tumor grade, tumor margin(infi ltrating vs pushing), and tumor necrosis (<5%absent, >10% present) were evaluated. The intratumoral and peritumoral LVD was determined in tumor vessel "hot spots" using light microscope (20 x magnifi cations) by four observers. The mean vessel counts in 3 hot spots per section was recorded.
Results: Table 1 . shows histologic parameters and LVD in pathologic stages 3 and 4 (T3 and T4) laryngeal SCC. In these patients the mean peritumoral LVD was 6.0 (T3-5.9 and T4-6.1), while the mean intratumoral LVD was 5. Background: Carcinoma ex-pleomorphic adenoma (CA ex-PA) is a rare malignant salivary gland tumor that arises in association with pleomorphic adenoma (PA). Both PA and CA ex-PA have a broad spectrum of histologic features and distinction from its histologic mimics may be diffi cult based on morphology alone. PLAG1 and HMGA2 gene rearrangements and amplifi cations are the most common genetic events in both PA and CA ex-PA; however, the utility of PLAG1 and HMGA2 abnormalities as adjunct molecular tests in the diagnosis of salivary gland tumors has not been well established. Design: FISH analysis for PLAG1 and HMGA2 was performed on 21 CA ex-PA (9 myoepithelial carcinomas (MECA), 10 Salivary duct carcinomas (SDC), 1 mucoepidermoid carcinoma, and 1 mixed MECA-adenocarcinoma NOS), 18 de novo carcinomas (11 MECA and 7 SDC), 16 PAs and 11 PA-histologic mimics (2 epithelialmyoepithelial carcinoma (EMC), 2 basal cell adenocarcinoma (BACA), 7 polymorphous low grade adenocarcinomas (PLGA)).
Results: All except 3 cases (86%) of CA ex-PA were positive for PLAG1 or HMGA2 rearrangements/amplifi cations. The three negative CA ex-PA were of SDC subtype and they showed a clear-cut benign PA component. In contrast, 17 out of 18 (94%) de novo carcinomas lacked abnormalities in PLAG1 or HMGA2 genes (p<0.01). PLAG1 or HMGA2 rearrangements were identifi ed in 7/9 (78%) hypocellular myxoid PAs and in 2/7 (29%) cellular PAs. Furthermore, all morphologic mimics of PA were negative for PLAG1 or HMGA2 rearrangements.
Conclusions: PLAG1 and HMGA2 rearrangements are the most common genetic events in CA ex-PA regardless of the histologic subtype. Unlike CA ex-PA, de novo SDC and MECA were negative for PLAG1 and HMGA2 abnormalities. Interestingly, rearrangements of PLAG1/HMGA2 were identifi ed in the majority of hypocellular PAs but only in a small subset of the cellular PAs. FISH ancillary test for PLAG1 or HMGA2 abnormalities can be used to distinguish between PA and its morphologic mimics. was performed. Clinical data and outcome parameters were obtained from medical records. Surgical pathology archival material was reexamined and formalin-fi xed paraffi n-embedded material was further evaluated with IHC for androgen receptor (AR) and HER2 expression. AR IHC (nuclear) staining was classifi ed as negative (<50% of tumor cells) or positive (>50% of tumor cells). HER2 IHC (membranous) staining was classifi ed as 1) none, weak (not crisp, faint) or strong (crisp, dark); and 2) <50% or >50% of tumor cells. HER2 scoring was classifi ed as: 0 = none; 1+ = weak, <50%; 2+ = weak >50% or strong <50%; and 3+ = strong >50%. Fluorescence in situ hybridization (FISH) with PathVysion HER2 DNA probe set (Abbott Molecular) was performed on all SDC and normal specimens. Interpretation followed ASCO/CAP 2007 guidelines. Positive predictive value (PPV) and negative predictive value (NPV) were estimated along with 95% score confi dence intervals. Results: Median patient age was 58y (range 32-75) and 23 (72%) were male. All 32 cases were AR positive. HER2 IHC scoring showed: 0 (7 cases, 22%); 1+ (4,13%); 2+ (2, 6%); and 3+, (19, 59%). HER2 FISH showed the following in chromosome 17: amplifi cation (19, 59%), polysomy (6, 19%), monosomy (1, 3%), and normal (6, 19%). Cases with a HER2 score of 0 were either normal (6) or monosomy (1); HER2 score 1+ and 2+ showed polysomy (6, 100%); HER2 score of 3+ represented amplifi cation (19, 100%). The PPV of a 3+ IHC score was 100% (95% CI=83.2-100) and NPV scores <3+ IHC was 100% (CI=77.2-100). Conclusions: HER2 overexpression can reliably predict HER2 amplifi cation in SDC. HER2 score of 3+, defi ned as strong membranous staining in >50% of tumor cells, showed a PPV of 100% for HER2 amplifi cation. The NPV for HER2 scores of 0-2+ was also 100%. This novel SDC HER2 scoring system may provide a cost-effi cient manner to determine eligibility for targeted therapy such as trastuzumab.
Regulation of Non-Coding RNAs by Human Papilloma Virus in the Pathogenesis of Head and Neck Squamous Cell Carcinoma
University of California, San Diego, San Diego, CA. Background: Most commonly known for its role in cervical cancer, human papillomavirus virus (HPV), primarily HPV16 and its oncoproteins E6 and E7, is also a major risk factor for oropharyngeal squamous cell carcinoma (OPSCC), a subset of head and neck cancers. Nonetheless, the molecular mechanism for the pathogenesis and progression of HPV-related oral cancer is poorly understood. MicroRNAs (miRNAs) are predicted to regulate up to 30% of protein-encoding genes, and are crucial for the pathological classifi cation of tumors and elucidation of the pathogenesis of oral cancers. Long non-coding RNAs (lncRNAs) have been demonstrated to regulate transcription factors that are closely associated with regulation of self-renewal and differentiation, tumor suppressors, and protooncogenes. This study sought to determine how HPV causes malignant transformation of normal oral cells through regulation of miRNA and lncRNA upon initial expression of the E6 and E7 oncoproteins. Design: Very early passage oral epithelial culture cells HOK and OKF4 were transfected with HPV16 expression plasmids, and analyzed with qPCR and RNAseq to determine lncRNA and EMT gene expression levels. Functional effects of let-7 and miR-296 were investigated through premiR transfection and forced expression of HPV16 E6/E7. Results: Transfection with HPV expression plasmids induced the stem cell genes Oct4 and Nanog, elevated Vimentin and inhibited of E-cadherin levels to promote an epithelial-to-mesenchymal (EMT) phenotype. Through qPCR-based arrays and RNAseq, the miRNAs miR-296, let-7, and miR-197 were determined to have the biggest differences in expression between control cell lines and those that expressed HPV16 oncoproteins. Overexpression of let-7 and miR-296 decreased cell proliferation compared to control, which effects were partially reversed with forced expression of HPV16. Let-7 also decreased cell proliferation by sensitizing cells to cisplatin and increasing the Bax/BCL2 ratio, but forced expression of HPV16 reversed this ratio.
Conclusions:
These results indicate that HPV16 can confer cancer stem cell characteristics to normal oral epithelial cells and induce the EMT phenotype by dysregulating miRs let-7 and miR-296. Further investigation of these miRs may elucidate the molecular mechanism of oncogenesis through HPV-regulated ncRNAs, and serve as both prognostic indicators and therapeutic targets for HPV-induced oropharyngeal cancers. . Other than the previously described predilection for supraglottic sites, Chi-square analysis found no correlation between p16 positivity and gender, stage, or smoking history. p16 status also was unrelated to overall 5 and 10 year survival. As most p16 positive tumors were supraglottic, survival studies were additionally performed on this group separately. Although p16 positive tumors showed a trend toward better overall survival, there was no statistically signifi cant difference (p=0.17).
As previously described, SqCCs of the larynx are rarely HPV-associated and show decreased rates of p16 positivity. Although supraglottic p16 positive tumors showed a positive trend, there is no defi nitive statistical evidence that p16 is associated with an improved outcome. Therefore, we feel that the use of p16 in the larynx, particularly in the absence of prototypic non-keratinizing morphology, is of minimal clinical utility. The histologic features of this tumor are not well characterized, much less its grading, which is controversial. The objective of this study is to provide a better characterization of MECA and its prognostic factors with the aim to establish a grading system for a better patient stratifi cation. Design: 49 cases of MECA were retrieved from the pathology fi le. The cases were subjected to a detailed histopathologic, immunohistochemical, and clinical analysis. Results: Median patient age was 61 years (25-90) with a female/male ratio of 1/1. Tumors were located in parotid (71%), submandibular gland (14%), and minor salivary glands (12%) with an average size of 3.7 cm (0.9-9.5). Tumors were classifi ed as de novo MECA in 22 cases (46%) and carcinoma ex pleomorphic adenoma (CAexPA) in 26 cases (54%). Histologically, all tumors showed invasive borders and most had multinodular growth pattern with a cellular periphery. In de novo MECAs, ductal formations were noted only in 4 cases and all had <10% ducts. Immunohistochemical stains were performed on 39 cases (77%), and each tumor was positive for keratin and at least one of the myoepithelial markers (S100, calponin, p63, and SMA). The other 11 cases showed the typical morphology of MECA. Tumor necrosis, mitotic count≥6/10HPFs, and severe pleomorphism were identifi ed in 35%, 46% and 22%, respectively. PNI, VI, and positive margins were noted in 12%, 14% and 48%, respectively. The median FU was 38 months. 5 patients had LN metastasis at presentation, 9 developed local recurrences, and 11 had distant metastases (lung in 82% Solid tumors generally depend on aerobic glycolysis (Warburg effect), producing huge amounts of lactic acid, which promotes tumor progression and contributes to radioresistance. Additionally, lactic acid inhibits proliferation of activated T-cells, which also depend on aerobic glycolysis and lactate secretion. (BD Pharmingen™) . The Qiagen DNA extraction kit was used to extract genomic DNA and it was tested for the presence of HPV using consensus SPF10 primers followed by gel electrophoresis. HPV genotyping was performed by TaqMan Real-Time PCR for HPV16, 18, 33 and 45. Results: 72 (11.9%) out of 604 patients were identifi ed with a second primary malignancy (SPM). Third primary malignancy prevalence rate was 3.0% (18/604) while a fourth primary malignancy rate of 0.5% (3/604) was established. Overall 57 males and 15 females between the ages of 36 to 78 (mean 58 +/-SD 9) were reviewed. The majority of SPM were located in the oral cavity (44%) and oropharynx (24%). Over 75% of these patients smoked and consumed alcohol. About one third of them (21pts) had HPV positive fi rst primary tumour. Among them, nearly 50% (10pts) developed a HPV positive SPM. Majority of the patients were HPV-16 positive (12pts), 1 patient had HPV-18 and 2 patients had co-infection of HPV-16 and 18 in their index tumor. Interestingly, among the patients who were HPV negative in their fi rst primary malignancy, approximately 35% a developed a HPV positive SPM. A low p16Ink4a positivity rate for both fi rst primary (16.4%) and SPM (16.4%) was established. Patients who were HPV/p16 positive in both primary and SPM had a signifi cantly higher 2-yr survival rate of 75% (95%CI 56.63, 93.38) compared to those that were HPV/p16 negative in both primary and SPM of 40% (95%CI 27.85, 52.15). Conclusions: HNSCC patients that were both HPV positive and p16 positive develop a SPM and these patients have a better survival compared to patients who did not harbour HPV infections and were also p16 negative.
Proliferative Grading Predicts Outcome in Myoepithelial Carcinoma
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Salivary Duct Carcinoma with Rhabdoid Features Is an Extremely Rare and Unique Subtype of Sarcomatoid Salivary Duct Carcinoma K Kusafuka, M Maeda, K Yamanegi, K Muramatsu, T Nakajima. Shizuoka Cancer Center, Sunto, Shizuoka, Japan; Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan; Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Background: Although salivary duct carcinoma (SDC) is a relatively common malignancy of the salivary glands, sarcomatoid variant of SDC (SSDC) is rare. The tumor cells showing rhabdoid features are extremely rare in SDC. Only one case of rhabdoid subtype was described as one of histological variations of SSDC. Design: We extracted salivary duct carcinoma with rhabdoid features (SDCRF) cases from the pathology fi les of Shizuoka Cancer Center, Toyohashi Municipal Hospital, and Hyogo College of Medicine Hospital during 1995-2013. We examined them clinico-pathologically and immunohistochemically. Immunostain was performed for pan-cytokeratin (CK), epithelial membrane antigen (EMA), gross cystic disease fl uid protein (GCDFP)-15, androgen receptor (AR), Her-2, epidermal growth factor receptor (EGFR), prostate-specifi c antigen (PSA), vimentin, p63, alpha-smooth muscle actin (ASMA), CK14, p53 and Ki-67.
Results: Five cases of SDCRF were selected. All cases were male with a mean of 59 years (range: 39-75 years), which included four parotid gland cases and one submandibular gland case. Two cases are alive with disease, whereas other two cases are dead. One case lost the follow-up. Histologically, four of fi ve cases showed carcinoma ex pleomorphic adenoma, widely invasive type. The invasive portion showed diffuse proliferation of non-coherent large ovoid or polygonal carcinoma cells showing eosinophilic cytoplasm and eccentric nuclei. In situ lesions were also seen in pleomorphic adenoma areas. Immunohistochemically, such cells were positive for pan-CK, EMA, GCDFP-15 and AR in all cases, whereas they were negative for vimentin. Four cases showed Her-2 overexpression and one cases was positive for EGFR. Only one case was positive for PSA. Such rhabdoid cells were negative for myoepithelial markers, such as p63, ASMA and CK14. The nuclear accumulation of p53 protein was infrequently observed, whereas such carcinoma cells showed high labeling index of Ki-67 in invasive areas. Finally, we diagnosed the carcinoma component of these cases to be "SDCRF". Conclusions: SDCRF is an extremely rare subtype of SSDC, and such a subtype indicates an aggressive clinical behavior, like conventional SDC. "The rhabdoid cells" in SDCRF should be distinguished from the plasmacytoid cells in other salivary gland tumors. The former are negative for myoepithelial markers. INK4a overexpression has been proposed as a potential biomarker for HPV presence in a variety of squamuous cell carcinomas (SCC) including those of head and neck. The aim of this study was to determine the relantionship between p16 INK4a expression and HPV presence in laryngeal (L)SCC. Design: Patients with LSCC diagnosed at a single institution from 1992 to 1994 were restrospectively evaluated according to sample availability. Clinico-pathological features were retrieved from institutional records. Fifty-four LSCC were tested for HPV DNA by PCR using three different protocols based in MY09/11 and GP5/6 primers. p16
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INK4a expression was examined by immunohistochemistry (IHC) in 44 of the tumors. p16
INK4a mRNA expression was analyzed through real-time quantitative reverse transcriptase-PCR in 34 cases. The results were correlated to p16
INK4a mutation information previously available. Results: All patients were male with ages of 61±16 years (mean ± SD). Ninety-one percent of tumors were at an advanced stage (49/54). All tumors were HPV-negative with all three detection methods in spite that all cases showed amplifi cation of internal controls. Four out of 44 (9%) cases overexpressed p16
INK4a by IHC. Two cases positive for p16
INK4a immunostaining for which genetic information was available harbored p16 mutations (one missense and one frameshift). p16 mRNA expression was 0.7±0.49 (mean±DS) and ranged from 0.01 to 2.2 with a median of 0.49. Eight out of 9 mutated cases presented p16
INK4a mRNA overexpression (above 0.49) whereas it was found only in 9 out of 25 non mutated cases (p=0.017, Fisher's exact test). Conclusions: Our results show that HPV implication in LSCC in our setting is, at most, marginal. p16
INK4a overexpression, both at protein and mRNA levels may refl ect p16
INK4a genetic alterations instead.
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Oral Preneoplastic Lesions: A Clinicopathological, Immunohistochemical and Molecular Approach AB Larque, C Marti, M Potrony, JA Puig-Butille, S Hakim, C Badenas, A Nadal, L Alos. Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Hospital Clínic, Barcelona, Spain; Fundació Clínic per a la Recerca Biomèdica, IDIBAPS, Barcelona, Spain. Background: Most of the patients with multifocal diachronic or synchronic squamous cell carcinoma (SCC) of the oral mucosa have also multifocal preneoplastic lesions. Smoking and alcohol are important carcinogenic agents , but in a large number of cases the etiologic factor is unknown, as occurs in the proliferative verrucous leukoplakia. With the aim of investigating oncogenetic events in the preneoplastic oral lesions in different settings, several oncogenes were explored, as well as the HPV-association. Design: Twenty patients with oral squamous cell carcinomas and preneoplastic lesions were included in the study. Ten patients met the proliferative verrucous leukoplakia condition. Clinicopathological data were recorded and lesions were histologically assessed. In all cases HPV analysis was carried-out by in situ hybridization (GenPoint HPV DNA Cocktail, Biotinylated, Dako) and immunohistochemistry for p16, p53, cyclin D1, and Ki 67 was performed. From 14 formalin-fi xed paraffi n embedded samples of 7 patients multiplex ligation-dependent probe amplifi cation was performed with the SALSA MLPA P175 Tumour-Gain probemix (MRC-Holland). Results: The patients were 14 females and 7 males with a median age of 65 (range 41-90). Seven patients were smokers, and 2 consumed alcohol. All SCC were negative for HPV. Increased CCND1 (11q13) and MYC (8q24) genes copy number was found in 83% and 50% of SCCs, respectively. Only 2 high-grade dysplasias showed increased CCND1 and MYC genes copy number, whereas low-grade dysplasias did not show any gene gain. Immunostain for p16 was negative in all tumors and dysplastic lesions. There was a positive correlation between the expression of p53, Ki67 and cyiclinD1 and the grade of dysplasia. Conclusions: Multifocal preneoplastic and SCC in the oral cavity are usually not associated with HPV-infection. The oncogene gains are a late event in the development of SCC.
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Oncogenic HOXA10 Is Regulated by the Tumor Suppressor miR-494 in Oral Cancer TN Liborio, HM Jung, EK Chan. University of Florida, Gainesville, FL; Federal University of Amazonas, Manaus, Amazonas, Brazil. Background: Squamous cell carcinoma (SCC) is one of the most common cancers of the oral cavity. MicroRNAs (miRs) are endogenous small non-coding RNAs and posttranscriptional regulators of gene expression in both normal and pathological processes. In our miRNA microarray analysis, miR-375 and miR-494 were identifi ed as the two most underexpressed in human oral SCC versus controls. HOXA10, belonging to the homeobox family of developmental genes, is reported to be aberrantly expressed in several cancer types. A previous report showed up-regulation of HOXA10 in oral SCCderived cell lines compared to human normal oral keratinocytes. HOXA10 is predicted as a candidate of both miR-375 and miR-494 target based on bioinformatics. This study aimed to analyze the interaction between miR-375/miR-494 and HOXA10 in oral SCC. Design: HOXA10 expression was measured using qRT-PCR in oral SCC, normal tissues, and transfected cells normalized to GAPDH. Oral cancer cell lines SCC-25 and CAL 27 were transfected with miR-375-mimic, miR-494-mimic, and miR-mimic negative control, using Lipofectamine 2000. Proliferation of transfected cells were monitored using the trypan blue method. Mann-Whitney U test and Two-tailed Student's t test were used for tissues and in vitro experiments, respectively. The statistical analyses were performed using GraphPad Prism 5.0. Results: Overexpression of HOXA10 was demonstrated in oral cancer tissues vs. normal tongue tissues (p=0.0048). HOXA10 was overexpressed in both early and advanced stages (p=0.052 and p=0.0046, respectively). Transient transfection of miR-494 in oral cancer cells reduced the expression of HOXA10 in SCC-25 and CAL 27 cells (p=0.0001 and p<0.0001, respectively) while miR-375 did not show any effect. Furthermore, both miR-494 and miR-375 reduced the proliferation of SCC-25 (p=0.0022 and p=0.0009, respectively) and CAL 27 (p<0.0001 and p=0.0038, respectively) cell lines. Conclusions: This study suggests that, in oral cancer, overexpression of miR-494 could lead to reduce the oncogenic expression of HOXA10, however HOXA10 is not a target for miR-375. Additionally, miR-494 and miR-375 reduces the proliferation of oral cancer cells, reinforcing their role as tumor supressors miR in oral cancer.
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P16 Immunohistochemistry Versus HPV16 DNA Status in Predicting Survival in Locally Advanced Oropharyngeal Squamous Cell Carcinoma SZ Liu, JE Heath, DP Zandberg, LM Schumaker, JC Papadimitriou, KJ Cullen.
University of Maryland, Baltimore, MD. Background: HPV status is an important prognostic marker in oropharyngeal squamous cell carcinoma (OPSCC) with the majority caused by HPV16 type (80%). HPV positive status confers a signifi cantly favorable prognosis. p16 immunohistochemistry (IHC) is increasingly used as a HPV surrogate marker. The prognostic signifi cance of focal p16 positivity has yet to be elucidated. We investigated p16 IHC scored both manually and by digital image analysis and compared its prognostic signifi cance vs. HPV16 DNA status in primary, locally advanced OPSCC. Design: We retrospectively identifi ed 165 cases of primary, locally advanced OPSCC (clinical stage III-IVB) diagnosed between 1992-2007 at University of Maryland Cancer Center with availabe paraffi n-embedded tumor. 156 patients had both p16 IHC and HPV16 PCR testing done on E6/E7 oncogenes, 5 patients had indeterminate HPV16 PCR testing, 4 patients had no additional tissue for p16 testing. The p16 status was scored by Aperio positivity algorithm on representative tumor and manually scored by a blinded pathologist on a 0-3 scale (0=negative, 3=diffuse, strong). Median overall (OS) was defi ned as time from last followup to diagnosis. Frequency analysis was used to determine the cutoff for p16 positive/negative status. Results: HPV16+ (n=98) did signifi cantly better than HPV16-patients (n=62), median OS of 103.4 vs. 16.4 months (p<0.0001).
Aperio positivity analysis (5% cutoff) showed p16+ (n=72) had signifi cantly better median OS than p16-patients (n=89): 97.4 vs. 14.8 months (p<0.0001). Manual scoring (2-3+ vs. 0-1+) of p16+ patients (n=69) vs. p16-patients (n=92) showed similar results: 97.8 vs. 16.5 months (p value <0.0001). Chi squared test of HPV16 vs. p16 manual or computerized scoring showed high correlation (p<0.0001), 19/156 cases were discordant. The discordant patients (HPV+, p16-or HPV-, p16+) still performed signifi cantly better than HPV-, p16-patients. Conclusions: P16 IHC is an alternative to HPV DNA based testing with similar prognostic results in locally advanced OPSCC. Weak focal p16 IHC was prognostically the same as p16-cases. Discordant HPV16, p16 patients may represent an intermediate risk group. AC McClary, RT Sweeney, J Biscocho, BR Meyers, L Neahring, KA Kwei, K Qu, X Gong, CD Jones, S Varma, JI Odegaard, B Rubin, T Ng, ML Troxell, RJ Pelham, JL Zehnder, PA Beachy, JR Pollack, RB West . Stanford University Medical Center, Stanford, CA; Genomic Health, Redwood City, CA; Cleveland Clinic, Cleveland, OH; University of British Columbia, Vancouver, BC, Canada; Oregon Health  Science University, Portland, OR. Background: Ameloblastoma is a locally destructive tumor of odontogenic epithelium that occurs in the jaw (maxilla and mandible) and often requires disfi guring wide local excision due to high rates of local recurrence and insensitivity to chemoradiation therapy. A comprehensive interrogation of the ameloblastoma genome has not been published primarily due to low tumor prevalence and exposure to decalcifi cation which severely compromises nucleic acid integrity. Only recently have methods emerged to allow for deep sequencing from formalin-fi xed paraffi n-embedded (FFPE) archival tissue. Design: RNA-seq was performed on archival FFPE blocks from two cases of ameloblastoma. Next, targeted next-generation sequencing of 9 samples of ameloblastoma, from 8 patients including the two investigated by RNA-seq, was performed using the Tru-Seq cancer panel (Illumina). Interesting fi ndings were then confi rmed as somatic via traditional Sanger sequencing of tumor-normal pairs in the 8 patients. The most signifi cant molecular fi ndings were then explored via Sanger sequencing in a multi-center cohort consisting of 37 additional cases. Finally, additional mechanistic studies were performed to query the functionality of select mutants. Results: Preliminary RNA-seq analysis revealed several interesting mutations in the initial two cases, including mutations in the Hedgehog, Ras-Raf-MEK-ERK, and fi broblast growth factor pathways. These mutations were confi rmed to be present and somatic in the initial larger test cohort of 9 cases. In addition, the genomic alterations were found to be present at high allele frequencies. Targeted sequencing of the larger multi-center validation cohort showed a majority of cases harbored at least one of the aforementioned mutations. Functional interrogation of one of the Hedgehog pathway mutants showed basal activation of the pathway, as well as resistance to various pharmaceutical pathway inhibitors. Conclusions: Our study represents the fi rst to profi le the genomic mutational landscape of ameloblastoma. Not only were several canonical mutations identifi ed that describe a majority of cases from multiple institutions, but the fi ndings provide new mechanistic insights into the neoplastic process.
Mutational Profiling of Ameloblastoma Identifies Common Gainof-Function Mutations
Novel Karyotypic Abnormalities in Salivary Gland Tumors MJ McDonald, MJ Horne, P Li, RK Virk, ML Prasad. Yale University School of
Medicine, New Haven, CT. Background: Recurrent chromosomal aberrations have been well described in soft tissue tumors but limited information is available in solid tumors. Recently, a growing number of molecular studies have identifi ed unique and recurrent genetic abnormalities in salivary gland tumors. We present novel and recurrent cytogenetic abnormalities in salivary gland tumors at our institution. Design: Fresh tissue from tumors was obtained at the time of surgery and cultured in RMPI 1640. Chromosome analysis was performed on in situ cultured cells using Yale Molecular Cytogenetics Laboratory standardized procedures. Cultured cells were treated with colcemid to induce metaphase arrest and trypsin to digest chromosomal proteins. Wright's stain was performed for G-banding. Clonal abnormality was defi ned by similar numerical and structural chromosome rearrangements observed in at least three metaphases. Results: Forty-seven primary salivary gland tumors (31 benign and 16 malignant) were successfully karyotyped between 4/2011 and 8/2013. Abnormal karyotypes were identifi ed in 55% (27/47) of tumors: 19 benign (61%) and 8 (50%) malignant. In the pleomorphic adenomas with abnormalities, 33% (5/15) were 8q12 rearrangements and 20% (3/15) were 12q13-15 rearrangements. Novel karyotypic abnormalities were identifi ed in 56% (15/27) of abnormal cases.
Conclusions:
Multiple novel karyotypic abnormalities were identifi ed in benign and malignant salivary gland tumors in addition to previously described recurrent abnormalities. The frequency with which karyotypic abnormalities are detected in salivary tumors paired with the continued identifi cation of novel cytogenetic abnormalities supports karyotyping all salivary tumors. The identifi cation of recurrent and novel chromosomal abnormalities will deepen our understanding of salivary tumorigenesis and may lead to the discovery of novel diagnostic, prognostic and predictive markers.
Prognostic Significance of CD163 Positive Tumor Associated Macrophages in Oropharyngeal Squamous Cell Carcinoma
M Mehrad, J Luo, JS Lewis. Washington University School of Medicine, St. Louis, MO. Background: Macrophages are the most abundant cancer stromal cells of the host immune system, and it is known that tumor-associated macrophages (TAMs) are a major cellular component of human cancers, yet their impact on cancer biology is still unclear. CD163 positive TAMs have been shown to correlate with tumor progression and poor outcome in a variety of cancer types. However, their role in oropharyngeal squamous cell carcinomas (OPSCC), most of which are associated with human papillomavirus (HPV), has not been studied to date. Design: CD163 immunohistochemistry was performed on a tissue microarray cohort of OPSCC cases with known clinical follow-up and HPV status (by RNA in situ hybridization [ISH] ). Expression was assessed visually by one study pathologist, and was graded separately in intra-and peri-tumoral regions based on the extent of staining (1 = patchy, 2 = moderate, 3 = abundant) and intensity (1 = weak, 2 = moderate, 3 = strong). A combined intra-and peri-tumoral score of 2 or 3 was considered low, and a combined score of 4, 5 or 6 as high. Survival curves were estimated by the Kaplan-Meier method. Results: A total of 183 patients, from 1996 to 2007, were studied, most of whom were men (88%) of Caucasian race (89%), and current or former smokers (67%). HPV RNA was positive in 81%. High (3+) intra-and peri-tumoral CD163 positivity was observed in 12% and 33% of the tumors, respectively. An overall combined high CD163 (4 or more) was seen in 55%. High CD163 was strongly associated with overall (p= 0.03) and disease free survival (p= 0.03). Among the HPV positive patients, high CD163 expression was even more strongly associated with survival, including overall (p= 0.02), disease specifi c (p= 0.02) and disease free survival (p= 0.02). There was also a correlation between high CD163 and patients receiving surgical treatment (p= 0.03) versus non-surgical, and with Caucasian race (p= 0.0002). However, no correlation with T or N-stage, co-morbidities, smoking, or drinking was found (p > 0.05). Conclusions: Increased number of CD163 TAMs correlates strongly with patient survival in OPSCC, including among HPV positive patients. This is a novel fi nding and may suggest that macrophages are heterogeneously activated depending on the tumor type and organ specifi c microenvironment. In particular, it supports the concept that immune responses to HPV positive OPSCC are important in its pathobiology. Background: Each year in the U.S., medical error results in up to 98,000 unnecessary deaths, over a million injuries and substantial cost. Given that pathologic diagnoses are one source of medical malpractice, second review of material from patients seeking treatment at our institution has been mandatory. The few prior studies have shown that second opinion pathology review results in a clinically major diagnosis change in a signifi cant minority of patients, ranging from 0.6% to 5.8%. In head and neck (HN) pathology, specifi cally, reported rates of changed diagnoses have been higher. Our goal was to evaluate the diagnostic discrepancy rates in cases referred to our institution and to identify specifi c areas with more susceptibility to errors that may require subspecialty pathology expertise. Design: Five hundred consecutive scanned HN pathology reports (2009-2011) from non-directed consults were retrieved and compared for discrepancies between the outside and in-house diagnoses. All cases had been reviewed by at least one of three HN pathology specialists at the time of referral. In our study, major discrepancies were defi ned as those resulting in a signifi cant change in patient management and/or prognosis. Additional follow-up information, when available, was used for confi rmation. Results: Major discrepancy occurred in 29 (5.8%) cases. The majority (27/29, 93%) of cases were from private practice institutions. Informative follow-up material was available on 16/29 (55.1%) cases, among which the second opinion was supported in 13 (81.2%). Twenty-two (75.8%) of the major discrepant diagnoses were on biopsy material, most commonly involving the oral cavity. This was 9 of 29 (31%) major discrepancies but 9 of 100 (9%) of all oral cavity consults. Overall, dysplasia versus invasion was the most common (9/29, 31%) area of discrepancy and site wise, sinonasal cavity (21.7%) followed by nasopharynx (18.2%) had the most discrepant diagnoses. Of the major discordant diagnoses, 16 (55%) involved a change from benign to malignant, 2 had a change from malignant to benign (7%), and the remainder (38%) involved tumor classifi cation. Conclusions: Despite widely available resources and ancillary studies, HN pathology is still a high-risk fi eld, prone to erroneous diagnoses, and our study supports the importance of second opinion review by a specialty pathologist for the best care of patients. It may be helpful to better educate residents and fellows in specifi c areas (such as oral dysplasia) in order to prevent future incorrect diagnoses.
Diagnostic Discrepancies in Mandatory Slide
USP6 Rearrangements Are Not Identified in Giant Cell Reparative
Granulomas of the Sinonasal Tract MJ Mentrikoski, RD LeGallo, SE Mills, EB Stelow. University of Virginia, Charlottesville, VA. Background: Giant cell reparative granuloma (GCRG) is a benign lesion that many consider a solid variant of aneursymal bone cyst (ABC). Although primarily an intraosseous lesion, in the sinonasal tract GCRP can involve the soft tissues and present as an exophytic, polypoid mass. Recently, many ABCs have been shown to indeed be neoplastic and harbor recurrent translocations involving the ubiquitin protease USP6. Due to their morphologic similarities, we hypothesized that GCRP of the sinonasal tract will harbor this translocation as well. Design: 13 cases of GCRG arising in the in the sinonasal tract were retrieved from the archives and clinical histories reviewed. Fluorescence in situ hybridization (FISH) utilizing a commercially available dual-color break-apart probe targeting the USP6 gene region (Empire Genomics, Buffalo, NY), was performed on full thickness sections of formalin-fi xed, paraffi n-embedded tissue. A case of nodular fasciitis (with a known USP6 disruption) was used as positive control. Interphase nuclei were scored using a fl uorescent scope and 150x oil immersion lens. 100 cells were scored as "intact" or "disrupted". A tumor was considered rearranged if greater than 10% of tumor cells were disrupted. Results: Cases included tumors from 8 males and 5 females. 9 cases occurred in the maxillary sinuses, 3 cases presented as nasal masses, and 1 case occurred in the sphenoid sinus. 11 of the cases were primary resections, while 2 were of recurrences. By FISH analysis, 4 cases were not interpretable (likely due to prior decalcifi cation procedure). No USP6 rearrangements were detected in the remaining 9 cases, with intact signals seen in all cells including both the individual spindle cells and giant cell nuclei of each lesion. Conclusions: Although USP6 rearrangements have been shown to occur in most ABCs and occasional GCRGs, those lesions diagnosed as GCRC in the sinonasal tract do not appear to harbor rearrangements. These results suggest that even though morphologic similarities exist between sinonasal GCRGs and solid ABCs, the two lesions appear to be genetically distinct. Further studies will be needed to completely evaluate whether these proliferations are true neoplasms.
Interobserver Variability in Assessing p16 Expression in Head and
Neck Squamous Cell Carcinoma M Merzianu, K Kanehira, N Sule, S Marimuthu, V Jayaprakash. Roswell Park Cancer Institute, Buffalo, NY. Background: p16 is widely used as a surrogate marker for human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC). Various cutoff values ranging from 35% to 75% have been proposed for a positive result for clinical practice and trials. We assess here the interobserver agreement in evaluating p16 expression in a HNSCC cohort of various sites. Design: HE and p16 slides of 196 HNSCC previously clinically tested for HPV status with p16 (mtm, Heidelberg, Germany) and in situ hybridization (HPV16/18 probe, Dako, Carpinteria) in our department were separately, independently evaluated by 3 observers with different experience in this assessment blinded to demographics, smoking status, original interpretation and tumor site. Presence of keratinization, percentage of p16 reaction (p16 % ) in tumor cells (1:<5%;2:5-25%;3:26-50%;4:51-75%;5>75%) and overall positive/negative/inconclusive interpretation of each observer without a preset cutoff was recorded. Discrepant p16 % and scores were resolved in a consensus meeting. Correlation of consensus p16 expression (p16 cons ) with tumor site, keratinization, and previous result was evaluated. Results: There were 62 oropharyngeal (OP), 60 oral (O), 20 overlapping (OOP), and 53 other primary sites SCC. Tumors were classifi ed as keratinized (K, 71%), nonkeratinized (NK, 21%) and ambiguous/mixed (8%). A total of 72 cases were p16 cons+ all with >50% expression. Most (96.7%) of p16 cons-cases had <25% expression. There was complete agreement between 3 observers in assessing p16 % in 76% of cases and disagreement in only 1%. An even higher agreement was seen in overall p16 scoring (k 0.96-0.98) regardless of observer experience. Compared with the original interpretation, there was 96% concordance and 4% discordant results (5 p16   +   ISH  -and 3 p16   -ISH   +   ) . p16 was expressed in 17% OSCC, 74% OPSCC, 30% OOPSCC and 17% other HNSCC, and in 81% NKSCC vs 20% KSCC (p<0.001); the latter were most frequently OPSCC. 64% OPSCC were p16 + in smokers and 100% in nonsmokers (p<0.006) whereas 18% non-OPSCC were p16 + in smokers and only 9% in nonsmokers (NS). Conclusions: This study confi rms excellent interobserver agreement in scoring p16 and would suggest 50% as an appropriate cutoff for positive reaction. Most p16 + tumors are NKSCC but many OPSCC show keratinization and this cannot be used alone as a selection criterion for testing. Tumors adjacent to OP show higher p16 expression then other HN sites which may explain OSCC p16 expression. The relatively high rate of p16 + in nonoropharyngeal SCC confi rm the need for additional testing to identify false positive results.
Primary Mucosal Melanoma of the Aerodigestive Tract, a Clinicopathologic and Immunohistochemical Study of 35 Cases
MC Mochel, P Adriano, DM Lyn, K Stefan. Massachusetts General Hospital, Boston, MA. Background: Primary mucosal melanoma of the aerodigestive tract (PMMAT) is a rare disease with poor survival and high rates of local recurrence and metastasis. Intraepithelial mucosal melanocytic proliferations associated with invasive melanoma may have distinctive diagnostic and prognostic features. The objective of this study was to evaluate the presence of mucosal malignant melanoma in situ (MMMIS) and perform a clinicopathologic review of PMMAT at our institution. Design: The clinical and histopathologic features of PMMAT in 35 patients were retrospectively analyzed. PMMAT cases and fi ve normal controls were evaluated immunohistochemically for microphthalmia-associated transcription factor (MITF). Results: PMMAT locations were sinonasal (32), oral (2), and laryngeal (1). Patient age was 30 to 90 (median 69 years) and the M:F ratio was 3:2. Of the 26 patients with clinical followup (range: 5 to 137 months, mean 32 months), 7 were alive with no evidence of disease (ANED), 7 alive with recurrent and/or metastatic disease (AWD), and 12 had melanoma-associated death (DOD). Histologic examination revealed inter-and intratumoral heterogeneity, including epithelioid, spindled, and small cell morphology. Determination of thickness was not possible in the majority of cases due to fragmentation. MMMIS, defi ned as a confl uent intraepithelial melanocytic proliferation of cytologically atypical melanocytes, was identifi ed in 21/33 cases with available epithelium. MMMIS within respiratory epithelium or glands was often subtle and diffi cult to identify on HE. In all cases of MMMIS, MITF staining confi rmed the presence of a confl uent cytologically atypical intraepithelial proliferation of melanocytes. Intraepithelial melanocytic proliferations without confl uent growth were considered as hyperplasia (6 cases); 2 of which showed cytologic atypia, and 4 showed no cytologic atypia. Followup of cases with associated MMMIS (mean followup 29 months) revealed 3 with NED, 3 AWD, and 10 DOD, while those without associated MMMIS (mean followup 33 months) consisted of 4 with NED, 3 AWD, and 2 DOD (one case lacked epithelium). However, this survival difference was not statistically signifi cant (p>0.05). Conclusions: PMMAT is a rare disease with a poor prognosis. MMMIS, highlighted by MITF, is often associated with PMMAT. While this retrospective evaluation suggests a worse prognosis for patients with PMMAT and associated MMMIS, further studies are required to establish the clinical importance of this fi nding, especially its potential relevance to the evaluation of surgical margins.
Epstein-Barr Virus-Infected Mucosal Epithelial Cells in Normals and Squamous Cell Carcinoma of the Base of Tongue and Tonsils
T Moore-Medlin, C-A Nathan, X Gu. Louisiana State Universtiy Health Sciences Center-Shreveport, Shreveport, LA. Background: In the oropharynx, the base of tongue and tonsils (BOT/T) are areas that are susceptible to risk factors and prone to developing squamous cell carcinoma (SCC). Epstein-Barr virus (EBV) infection is very common in adults with seroprevalence rates in excess of 90% worldwide. Repeat infection and amplifi cation of virus by replication in epithelial cells has been associated with both epithelial and B cell malignancies. Although there are many reports of EBV in oral mucosa, the study of EBV-infected epithelial cells in BOT/T is limited. We have analyzed expression of EBV-encoded RNA (EBER) and latent membrane protein (LMP) in the epithelial cells in normal mucosa and SCC in the BOT/T region. Design: Cases of BOT/T biopsies or resections, including 48 benign and 220 SCC, were selected from our archive materials from 2000 to 2012. Four-micron sections were prepared. EBER in-situ hybridization and LMP immunohistochemical stains were performed following standard laboratory protocols. Results: Ten of the 48 benign BOT/T squamous mucosa were positive for EBER and 1 of EBER positive cases was positive for LMP. In the SCC group, 64 of 220 cases were positive for EBER and 14 of the 58 EBER positive cases were positive for LMP. In the SCC group, EBER positive epithelial cells were seen in the normal epithelium, the in situ carcinoma and the invasive carcinoma.
Conclusions: EBER positive cases were only slightly increased in the SCC group over the benign group. However, positive LMP expression was much higher in EBER positive cases in the SCC group than in the benign group. These fi ndings suggest that EBV-infection in BOT/T epithelial cell in SCC group has a high potential for acquiring an oncogenic capacity. Other risk factors may promote the persistence of EBV in a latent phase in epithelial cells and work in concert with EBV to induce carcinogenesis. Background: Sinonasal HPC-like tumor (glomangiopericytoma) is a distinct benign neoplasm with perivascular myoid differentiation. Its genetic signature has not been yet defi ned and it remains debatable if it shares any pathogenetic relationship with other morphologically similar tumors, such as solitary fi brous tumor (SFT), glomus tumor and pericytoma. As recent genetic abnormalities have been described in these related tumors, such as NAB2-STAT6 fusions in SFT, miR143-NOTCH fusions in glomus tumors and GLI1 rearrangements in pericytoma, we sought to investigate a group of sino-nasal lesions with hemangiopericytic phenotype to establish a more objective classifi cation based on molecular markers. Design: RT-PCR for NAB2-STAT6 with target sequencing for validation, and STAT6 IHC was performed on 5 SMA-positive sinonasal HPC-like tumors and 3 benign SFTs of sinonasal area (supported by CD34 staining). These tests were also performed in a control group, comprised of 3 benign SFTs, 5 malignant SFTs (including 2 dedifferentiated SFTs), 1 mammary myofi broblastoma, 2 infantile myofi bromatoses, and 2 angioleiomyomas. In addition, FISH for NOTCH2, NOTCH3 and GLI1 was performed on the 5 HPC-like tumors.
Results: NAB2-STAT6 gene fusion and STAT6 immunoreactivity was detected only in the CD34-positive SFT lesions, benign or malignant, regardless of anatomic location. Conventional and dedifferentiated areas of dedifferentiated SFTs that were interrogated separately were also positive for NAB2-STAT6 fusion and STAT6 overexpression. Sinonasal HPC-like tumors were negative for NAB2-STAT6 gene fusion or STAT6 by IHC, as well as additional non-SFT controls. Furthermore, no gene abnormalities were identifi ed in NOTCH or GLI1 in the sino-nasal HPC-like tumors tested.
Conclusions:
The presence of NAB2-STAT6 gene fusion plays a key role in unifying the concept of SFT at all anatomic locations. Our fi ndings confi rm that sinonasal HPClike tumor is a distinct entity from all other morphologic mimics, of which molecular characterization is yet to be determined. The presence of an SFT-like lesion arising in the sinonasal location can be confi rmed in diffi cult cases by either NAB2-STAT6 RT-PCR or STAT6 reactivity. CK Ng, S Piscuoglio, B Weigelt, R Lim, YH Wen, RA Ghossein, N Katabi, JS Reis-Filho. Memorial Sloan-Kettering Cancer Center, New York, NY. Background: Recurrent translocations have been shown to be a feature of numerous malignancies. A subset of salivary gland tumors has recently been found to harbor highly recurrent translocations (e.g. mucoepidermoid, adenoid cystic, mammary analog secretory, and clear cell carcinomas). Using massively parallel RNA sequencing, we sought to defi ne whether acinic cell carcinomas and polymorphous low-grade adenocarcinomas of the salivary glands would be underpinned by recurrent fusion genes. Design: Six fresh/frozen acinic cell carcinomas and 5 polymorphous low-grade adenocarcinomas of the salivary glands were retrieved from the Tumor Procurement Service of Memorial Sloan-Kettering Cancer Center. All cases were reviewed by three pathologists. RNA was extracted from microdissected representative frozen sections and subjected to paired-end RNA sequencing (Illumina HiSeq2000). Expressed fusion genes and 'readthroughs' were identifi ed using a combination of Chimerascan and deFuse algorithms. To fi lter common RNA sequencing artifacts, fusion transcripts and 'readthroughs' identifi ed in 47 normal samples were removed from the results of the analyses of salivary gland tumors.
RNA Massively Parallel Sequencing Analysis of Acinic Cell Carcinomas and Polymorphous Low-Grade Adenocarcinomas of the Salivary Glands
Results: In acinic cell carcinomas, Chimerascan identifi ed 388 and 14 expressed fusion genes and 'readthroughs', respectively, whereas deFuse identifi ed 128 and 46 expressed fusion genes and 'readthroughs', respectively. Only six expressed fusion genes were identifi ed by both approaches (MYL12B-NCAPG, OXR1-NR4A3, and none was found in >1 case. No case harbored the ETV6-NTRK3 fusion gene characteristic of mammary analogue secretory carcinomas. In polymorphous lowgrade adenocarcinomas, Chimerascan identifi ed 92 and 36 expressed fusion genes and 'readthroughs' respectively, whereas deFuse identifi ed 22 and 65 expressed fusion genes and 'readthroughs' respectively. Only three expressed fusion genes (ACTN4-PRKD2, TFG-GPR128 and NCALD-PLAG1) and two 'readthroughs' (PPP1R1B-STARD3 and PRPSAP1-QRICH2) were identifi ed by both approaches. The PPP1R1B-STARD3 was found in two out of the fi ve cases sequenced. Conclusions: Unlike other types of salivary gland tumors, acinic cell carcinomas and polymorphous low-grade adenocarcinomas of the salivary gland are not driven by highly recurrent fusion genes. We also confi rmed the previous observations that acinic cell carcinomas of the salivary glands lack the ETV6-NTRK3 fusion gene. 
Background:
The majority of squamous cell carcinomas of the tonsil are HPV-related; however, in contrast with HPV-related cervical squamous cell carcinomas, no distinct precursor lesions have been identifi ed. It has been hypothesized that the precursor lesions occur deep in the tonsillar crypts and are therefore diffi cult to appreciate. Nonetheless, to our knowledge no evidence of the existence of such lesions has been reported. Design: 51 consecutive tonsillar squamous cell carcinoma cases diagnosed between 2010 to present were identifi ed. All cases were stained for p16, which was used as a surrogate marker for HPV. The presence of continuous block-like nuclear and cytoplasmic staining was considered positive; weak, patchy staining was considered negative. Weak diffuse staining with focal accentuations was considered equivocal. Residual surface or crypt epithelium was identifi ed and surface epithelial dysplasia and dysplasia involving the crypts was assessed separately. If identifi ed, squamous dysplasia was classifi ed as basaloid and differentiated and graded according to the upper aerodigestive tract grading scheme. Squamous cell carcinomas were classifi ed into keratinizing and nonkeratinizing.
Results:
The results of our study are presented below: Conclusions: Dysplasia involving tonsillar crypts is only rarely identifi ed in patients with squamous cell carcinomas, most likely because the invasive squamous cell carcinomas overgrow the precursor lesions but may preserve the outline of the crypts.
Crypt dysplasia is present in p16 positive non-keratinizing squamous cell carcinomas. Surface dysplasia is more frequently seen in keratinizing p16 negative squamous cell carcinomas. A larger number of benign tonsils need to be studied to assess the frequency of dysplasia in non-tumor bearing tonsils. were retrieved from the Oral Pathology Department of our institution. Oral and Maxillofacial diagnoses were grouped into nine categories, and lesions were evaluated for age, gender, anatomic location and pathological diagnosis. Data was analyzed using descriptive statistics. Results: A total of 3150 oral and maxillofacial biopsies were recorded for patients between 0-18 years from a total of 48,268 adult and pediatric biopsies over the ten year time period. The diagnostic category with the largest number of specimens was odontogenic cysts and periapical pathology. The most common salivary lesion was mucocele. There were three cases of squamous cell carcinoma and one case of mucoepidermoid carcinoma in this pediatric population. No other malignant lesions were noted. Additionally one case of sarcoidosis was noted. Conclusions: Although the vast majority of pathology encountered in this cohort was benign, many lesions required intervention to improve quality of life for the patient. Therefore early recognition of oral lesions in children is critical and a complete oral examination should be an integral part of a child's well visits. Furthermore the degree and the nature of the lesions found in this cohort corroborate American Academy of Pediatrics' recent efforts to include oral health screenings in child well visits. Background: Renal transplant recipients are highly susceptible to skin cancer in sun exposed areas of the body particularly the head and neck skin. Immune suppression, ultraviolet light exposure and cutaneous HPV (HPV ) infection are believed to be important etiologic factors. In an attempt to further clarify the pathogenic mechanisms involved in the process of malignant transformation we investigated the morphologic features and immunophenotypic characteristics of premalignant skin lesions in a cohort of kidney transplant patients. Design: Sections of skin biopsies taken from 37 kidney transplant recipients were examined microscopically. Fifty nine premalignant lesions were identifi ed and were immunohistochemically stained for p16, p53, Ki-67 and Bcl-2. p16 was considered negative if areas of nuclear and cytoplasmic staining were < 25%, while 25-50%, 50-75% and >75% were scored as 1+,2+ and 3+ respectively. Positive staining for p53 and Ki-67 was scored as 1+, <25%, 2+, 25-50% and 3+, > 50%. Bcl-2 was scored as positive, > 10% or negative, < 10 %. Results: The average numbers of invasive squamous cell carcinoma and premalignant skin lesions that developed during≥ 5 years post transplantation period were 6.4 and 5.1 per patient respectively. Two morphologically distinct types of precursor lesions were identifi ed; dysplasia with Bowenoid features (BD) (31 cases) and premalignant keratosis without Bowenoid features (NBD) including hypertrophic and atrophic actinic keratosis (28 cases). The immunohistochemical profi les differed considerably between the two types of lesions with regard to p16, Ki-67 and Bcl-2 [ Table 1 ] while no difference was observed in p53 staining. Conclusions: The observed differences in morphologic features and immunohistochemical profi les between BD and NBD are highly suggestive of distinct etiology and pathogenesis. p16 over expression and higher Ki-67 labeling scores in BD are consistent with a relationship to HPV analogous to that observed in mucosal lesions . Strong and diffuse p16 staining could possibly be used as a surrogate marker for HPVrelated skin lesions similar to the mucosal ones. However, unlike HPV-related mucosal lesions of the head and neck, there was no signifi cant difference in p53 expression.
Bcl-2 over expression may be a unique feature of the cutaneous lesions. Background: Carcinoma ex-pleomorphic adenoma (CPA) is defi ned as a pleomorphic adenoma (PA) from which a malignancy is derived. It is stratifi ed according to the extension of penetration of the malignant component into non invasive, minimally invasive and invasive. The fi rst two groups have an excellent prognosis, similar to that of a PA, while the latter has a more guarded prognosis. The WHO classifi cation of Salivary Gland tumors defi nes 1.5mm invasion as the threshold to distinguish frankly invasive carcinomas. Nevertheless, this is a widely disputed matter as others suggest that a higher threshold (4-6mm) should be accepted. To contribute to this discussion we studied a series of 58 cases of CPA aiming at evaluating which extra-capsular extension threshold impacted on prognosis. Design: Fifty-eight cases of CPA, diagnosed between 1982 and 2013, were reviewed. Clinical data was obtained from patient's charts. Measurement of the extent of invasion used a calibrated low-power objective for tumors under 3mm and a transparent ruler placed directly onto the slide for the remaining, perpendicularly to the capsule of the pre-existing PA, and was expressed in mm. Eight cases were excluded due to fragmentation of the specimen.
No metastases or deaths occurred in non invasive cases or with invasion 1.5mm. Twenty-nine cases had between 2.5mm and 12mm extent of invasion, 11 with disease progression and of these 9 died. This group had a signifi cantly different diseasefree and overall survival. There were no cases with invasion >1.5mm and <2.5mm. Conclusions: Our data shows that patients with 1.5mm extent of invasion have good prognosis. The minimum extent of invasion that resulted in death was 2.5mm, not in agreement to the fi ndings of recently published series. Of note, 18 cases with≥2.5mm did well, confi rming that others factors beside the extent should be considered in the clinical management of these patients. Due to the fact that we did not have cases with >1.5mm and <2.5mm extension we cannot suggest a higher threshold than the one considered by the WHO. Background: Polymorphous low grade adenocarcinoma (PLGA) is a tumor of minor salivary glands that exhibits considerable morphologic overlap with adenoid cystic carcinoma (ACC) and cellular pleomorphic adenoma (PA), especially in small biopsy specimens. Unlike these other tumor types, PLGAs do not harbor a myoepithelial component; yet their frequent positivity for p63 diminishes the usefulness of this particular myoepithelial marker as a discriminating immunostain. P40 is an antibody that recognizes Np63, a p63 isoform that is more specifi c than p63 for true myoepithelial differentiation. As such, p40 immunostaining could help distinguish PLGAs from ACCs and PAs. Design: P63 (4A4; BioCare Medical, Concord CA) and p40 (BC28, Biocare) immunohistochemistry was performed on paraffi n embedded, formalin fi xed tissue from 11 PLGAs, 101 ACCs, and 31 PAs. Eight of the PLGAs were stained on whole sections, while the remaining tumors were present on tissue microarrays. Antigen retrieval with high pH buffer was followed by primary antibody incubation for 32 minutes. Staining was performed on an automated stainer using an Ultra View detection as per manufacturer's instructions (BenchMark Ultra, Ventana Medical Systems Inc., Tucson AZ). Results: All 11 PLGAs (100%) were positive for p63 but completely negative for p40. Among ACCs, 91 of 101 (90%) were positive for p63 and 90 of 101 (89%) were positive for p40. The single discordant p63+/p40-ACC exhibited solid architecture and high grade features not typically seen in PLGA. Among PAs, 21 of 31 (68%) were positive for p63 and 13 of 31 (42%) were positive for p40. For the PAs, the discordant p63+/ p40-staining pattern was seen only in the chondromyxoid stroma. The cellular ductal component of the PAs were consistently either p63+/p40+ or p63-/p40-. Conclusions: PLGA consistently exhibits a p63+/p40-immunophenotype that can help distinguish it from ACC and cellular PA, tumors that characteristically demonstrate concordant p63 and p40 immunostaining patterns. A p63/p40 immunohistochemical panel can provide a valuable tool for making the distinction between these morphologically similar but clinically divergent entities.
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Alcohol-Dysregulated MicroRNAs in the Pathogenesis of Oropharyngeal Cancer MA Saad, SZ Kuo, E Rahimy, H Zheng, WM Ongkeko, J Wang-Rodriguez. University of California, San Diego, San Diego, CA. Background: Though alcohol consumption has been implicated in the pathogenesis of oropharyngeal cancer, the molecular mechanism for the pathogenesis and progression of alcohol-related oropharyngeal cancer remains poorly understood. Recent advances in the discovery and understanding of non-coding RNAs (ncRNAs) have indicated that these RNAs are not transcriptional noise, but rather have critical roles as transcriptional and post-transcriptional regulators and as guides for chromatin-modifying complexes. MicroRNAs are one of the key ncRNAs that have a profound effect on a myriad of biological processes including oncogenesis and tumorigenesis. Our central hypothesis is that alcohol-mediated dysregulation of specifi c microRNAs is critical to the pathogenesis and progression of oropharyngeal carcinoma. Design: Using next generation sequencing analysis, we analyzed the non-coding RNA of 136 head and neck squamous cell carcinoma (HNSCC) patients. In order to further investigate these microRNAs, we exposed a panel of normal oral epithelial cell cultures/cell lines to low, medium, and high levels of ethanol (.1 to 1% by volume) for 4 weeks to mimic social, moderate, and heavy drinkers, respectively and performed qPCR microRNA array to determine alcohol regulation of microRNAs in vitro. We then performed functional assays on miR-30a-5p and miR-934.
Results:
We have identifi ed a panel of 8 microRNAs that are differentially expressed between alcohol drinkers and non-drinkers from analysis of RNAseq clinical data. In our in vitro experiments, we have identifi ed microRNAs that are differentially regulated as a result of alcohol exposure, including those identifi ed from the clinical data. Of the microRNAs identifi ed, we have selected miR-30a-5p and miR-934 for further investigation. Our preliminary data indicate that ectopic expression of both these microRNAs resulted in increased expression of the stem cell genes, CD44, Oct3/4, Nanog, BMI-1. Furthermore, forced expression of these microRNAs resulted in increased proliferation and inhibition of cisplatin-induced apoptosis signifying the malignant transformation of normal oral cells. Conclusions: Our results indicate that the identifi cation of key differences in microRNA expression between control and alcohol-exposed cells will result in discovering genes and events associated with oral cancer initiation and progression. Potential key microRNAs could serve both as prognostic indicators and therapeutic targets, leading to more effective treatments for alcohol-associated oropharyngeal cancer.
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DOG1, p63, and S100 Protein: A Novel Immunohistochemical (IHC) Panel in the Differential Diagnosis of Oncocytic Salivary Gland Neoplasms AC Schmitt, C Cohen, MT Siddiqui. Emory University School of Medicine, Atlanta, GA. Background: Oncocytic features are commonly identifi ed in salivary gland neoplasms, which include Warthin's tumor (WT), acinic cell carcinoma (AciCC), mucoepidermoid carcinoma (MEC) and oncocytoma (ONC). This study utilized a DOG-1, P63 and S-100 IHC staining panel to subclassify these salivary gland neoplasms with oncocytic differentiation. Design: 31 Fine Needle Aspiration Cell Blocks (CB) of oncocytic salivary gland neoplasms (16 WT, 10 AciCC, 3 MEC, and 2 oncocytoma [ONC] , and 75 salivary gland resections (7 WT, 27 AciCC, 36 MEC, 2 high grade adenocarcinomas [ADC], 2 ONC, and 1 papillary cystadenoma [PC]), were immunostained for DOG-1, p63, and S100.
Results:
Cytology Data N= 31 DOG-1 + (%) P63 + (%) S-100 + (%) WT (16) 0/16 (0%) 14/16 (87.5%) 0/16 (0%) AciCC (10) 7/10 (70%) 0/10 (0%) 0/10 (0%)
Surgical Resection Data N= 75 DOG-1 + (%) P63 + (%) S-100 + (%) WT (7) 0/7 (0%) 6/7 (86%) 0/7 (0%) AciCC (27) 25/27 (93%) 3/27 (11%) 2/27 (7%) MEC (36) 19/36 (53%) 35/36 (97%) 0/36 (0%) ADC (2) 0/2 (0%) 1/2 (50%) 0/2 (0%) ONC (2) 0/2 (0%) 2/2 (100%) 0/2 (0%) PC (1) 1/1 (100%) 1/1 (100%) 0/1 (0%)
an association between mast cell density and the expression TGF-beta at the earlier stages of lip carcinogenesis. Design: NL (n=18) and AC (n=69) samples were obtained from the archives of the Oral Biology and Pathology laboratory of the University of Concepcion, College of Dentistry. Samples were processed for immunohistochemical detection of TGF-beta and tryptase-positive mast cells. A score of epithelial expression of TGF-beta (intensity by extension) and dichotomic TGF-beta expression (TGF-high and TGF-low) using the median score as the cut off value were obtained. Mast cells were quantifi ed at intraepithelial, papillary and reticular stroma (30 fi elds, 400x). Expression of TGFbeta1 mRNA was measured by qRT-PCR in 14 AC samples and compared to normal oral mucosa, using GAPDH as the housekeeping gene. Double immunofl uorescence was used to assess co-localized expression of TGF-beta with mast cells by confocal microscopy (CMA Bio Bio).
Results: Epithelial TGF-beta expression was signifi cantly increased in AC as compared to NL (P <0.001, Mann-Whitney). In addition, a 4-fold increase in TGF-beta1 mRNA was found in AC as compared to normal oral mucosa. Mast cell density was increased in papillary and reticular stroma of AC as compared to NL (P <0.001), with no differences in intraepithelial mast cell infi ltration between NL and AC. AC and NL samples with a high expression of TGF-beta had signifi cantly higher mast cell density at the papillary stroma than samples with low TGF-beta expression (P<0. Background: MASC is a recently recognized low-grade salivary carcinoma characterized by an ETV6 rearrangement. Before its recognition, MASC was frequently classifi ed as acinic cell carcinoma (AcCC). Mammaglobin (Mamma)  S100-protein are useful in distinguishing MASC from AcCC. Low-Grade Salivary Duct Carcinoma (LGSDC) also histologically overlaps with MASC. However, LGSDC  High-Grade Salivary Duct Carcinoma (HGSDC), a LGSDC-look-alike, have not been characterized with respect to Mamma. Here we examine IHC and gene profi les in the context of distinguishing MASC from look-alikes. Design: 37 cases were studied (Table 1) for Mamma, S100, DOG1,  GATA-3 expression by IHC, HER2 (CISH)  ETV6 (FISH). Results: After study, 3 tumors (two called AcCC, one called undifferentiated carcinoma) were reclassifi ed as MASC; two were Mamma+/S100+, the third was Mamma+/S100-. A recurrent Mamma+/S100-/HER2 amplifi ed tumor was reclassifi ed as in-situ HGSDC (initially called cystadenocarcinoma). Background: Keratocystic odontogenic tumor (KCOT) is a benign uni-or multicystic, intraosseous tumor of odontogenic origin with a potential infi ltrative behavior. Therefore, a correct histopathological diagnosis with the exclusion of a radicular or follicular cyst is mandatory to justify the more aggressive surgical treatment. Despite characteristic histopathological features (e.g. parakeratinized stratifi ed squamous epithelium without rete ridges, palisading basal cells) the differential diagnosis of KCOT is sometimes diffi cult and raises the need of ancillary testing. Due to the fact that KCOT is in some cases part of the inherited naevoid basal cell carcinoma syndrome (NBCCS) with a strong expression of EpCAM in basal cell carcinoma, the expression of EpCAM in KCOTs, radicular and follicular cysts was examined. Design: Diagnosed between 1993 and 2010, 128 KCOTs, 147 follicular cysts and 115 radicular cysts were retrieved from the archives of our institute and installed in 35 paraffi n tissue microarrays (PTMAs) (core diameter: 4 mm). The PTMAs were stained immunohistochemically with a monoclonal mouse antibody (anti-EpCAM; clone Ber-EP4, dilution: 1:100; Dako) using an automated stainer (Benchmark, Ventana). Results: 89% (114 cases) of the KCOTs expressed EpCAM in the squamous epithelium in a heterogeneous fashion: 35% (46 cases) displayed a weak (Figure 1 C) , 42% (54 cases) a moderate (Figure 1 B) and 9,4% (12 cases) a strong basal and parabasal staining ( Figure 1A) . In squamous epithelium with underlying infl ammation, EpCAM expression was reduced or lost. 1,6% (2 cases) showed only a superfi cial staining pattern. 7% (14 cases) of the KCOTs were negative for EpCAM in contrast to 70% (103 cases) of the follicular cysts (Figure 1 D) and 99% (114 cases) of the radicular cysts (Figure 1  E) . Two follicular cysts (2%) displayed a weak to moderate expression in the basal/ parabasal layer whereas 28% (42 cases) showed a weak to strong EpCAM expression in the superfi cial epithelial layers. Only one case of the radicular cysts expressed EpCAM in a few cells in the superfi cial epithelial layers.
Conclusions
Conclusions:
The immunohistologically detected expression of EpCAM in the basal and parabasal layers of the squamous epithelium may be helpful in the diagnosis of KCOTs.
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NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates H Sun, S Zhang, M Bhattacharjee, RE Brown. University of Texas Medical School at Houston, Houston, TX. Background: NUT carcinoma is a rare entity arising primarily in the midline of teenagers and young adults. Genomically, it is associated with a mutation in the nuclear protein in testis (NUT) gene and most commonly, a translocation involving the BRD4 and NUT genes. The resultant is a partial or near total block in differentiation of tumor cells into mature squamous elements. Such tumors are resistant to conventional therapy with a reported mean survival at less than 1 year. Design: A series of two cases with genomic confi rmation as NUT midline carcinoma were studied by morphoproteomic analysis using immunohistochemical probes for the following protein analytes: CD133 and Sox2 as markers of stemness; phosphorylated (p)-insulin-like growth factor (IGF)-1R (Tyr1165/1166), p-mTOR (Ser 2448) and p-Akt (Ser 473) as mTORC2 pathway and promoters of stemness; and Sirt (silent mating type information regulation 2 homolog) 1 and c-Myc as molecular impediments to differentiation. Results: Variable expression of stemness markers, CD133 and Sox2 was evident in the undifferentiated cells of the tumor and virtually absent from the squamous elements, when present. The mTORC2 pathway was constitutively activated and overexpressed in the undifferentiated cells as evident by nuclear p-mTOR (Ser 2448) and p-Akt (Ser 473) co-expression and the upstream effecter, namely p-IGF-1R (Tyr1165/1166). Sirt1 and c-Myc were highly expressed in the nuclei of the undifferentiated cell component. Conclusions: These morphoproteomic fi ndings coincide with the genomic and fusion protein data regarding the ability of BRD-NUT fusion protein to inhibit differentiation and promote stemness. Additionally, the presence of a constitutively activated IGF-1R/ mTORC2/Akt pathway and overexpression of Sirt1 and c-Myc in NUT cases likely contribute to the stemness and the block in differentiation, respectively. The ability of histone deacetylase inhibitors and specifi cally, vorinostat to dephosphorylate Akt and to downregulate Sirt1 signaling; and the report by Schwartz, et al. of preclinical studies showing that vorinostat promotes differentiation and growth inhibition in NUT xenograft models and an objective clinical response in a patient with NUT midline carcinoma provides a therapeutic correlate to the morphoproteomic fi ndings in this report. Analysis of the Anti-Tumor Effects of V-ATPase Inhibitor, Concanamycin A1, on Oral Squamous Cell Carcinoma H Yoshida, Y Wang, T Kiyoshima, H Sakai. Kyushu University, Fukuoka, Japan. Background: V-ATPase is involved in the acidifi cation of the microenvironment around/ in solid tumors, such as oral squamous cell carcinoma(OSCC). V-ATPase is thought to induce tumor invasion and multi-drug resistance in several malignant tumors. However, there is little information regarding the effects of V-ATPase inhibitors on OSCCs. Design: We attempted to assess the effect of V-ATPase inhibitor, concanamycin A1 (CMA), on cell proliferation and apoptosis of OSCC cells (MISK81-5, SAS, HSC-4 and SQUU-B) in vitro. The effects of CMA on the cell viability and apoptosis were investigated by MTS assay and TUNEL staining, respectively. The mRNA and protein expression levels of apoptosis-related molecules after CMA treatment were analyzed by qRT-PCR and Western blotting, respectively. Results: CMA treatment for 48 hr signifi cantly suppressed the cell growth at low concentrations, and induced apoptosis in MISK81-5, SAS, and HSC-4 cells, but SQUU-B cells were highly resistant to CMA. Compared the expression of the proand anti-apoptotic factors in the SQUU-B cells with that in CMA-sensitive OSCC cells after treatment with CMA, whereas CMA activated p38, one of MAPK, in the CMA-sensitive OSCC cells, phosphorylation of p38 was not observed in SQUU-B cells. Moreover, CMA treatment induced comparative increase in Bcl-2 expression in the SQUU-B cells compared with that in the CMA-sensitive cells. However, when the SQUU-B cells were treated with CMA and a histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), the SQUU-B cells became more susceptible to the CMA-induced apoptosis. SAHA treatment led to a signifi cantly decreased Bcl-2 expression levels in comparison with that observed in the SQUU-B cells treated with CMA alone. Down-regulation of Bcl-2 partially induced decrease of the cell viability in the SQUU-B cells treated with CMA. Conclusions: Our results indicate that CMA could have an anti-tumor effect on OSCCs and that the combination of CMA with SAHA may exhibit synergistic anti-cancer activity in certain CMA resistance cells. Background: Alcohol use is one of the primary risk factors for head and neck squamous cell carcinoma (HNSCC), yet the mechanism by which alcohol induces oropharyngeal cancer remains unclear. Although ethanol itself is not carcinogenic, acetaldehyde, or ethanal, the fi rst metabolite of alcohol via the enzyme alcohol dehydrogenase, has been established as a suspected carcinogen. Long non-coding RNAs (lncRNAs) constitute a family of RNA longer than 200 nucleotides that do not code for proteins, but instead infl uence transcription factors associated with regulation of oncogenes, tumor suppressor proteins, self-renewal, and differentiation. This study sought to determine those key lncRNAs whose dysregulation by ethanol result in the acquisition of cancer stem cell properties in normal oral epithelial cells. Design: Two normal oral keratinocyte cell lines (OKF4 and OKF6) were treated with various doses of 100% ethanol for 28 days to represent long-term alcohol use. The same cell lines were also treated with acetaldehyde for 72 hours to better investigate the in vivo mechanism of alcohol-induced HNSCC. Relative lncRNA and mRNA gene expression in ethanol treated cells were compared with that of parental cells through qPCR arrays. Results: Comparison of relative lncRNA expression in ethanol treated cells with that of parental cells revealed that six lncRNAs (SAF, Zeb2Nat, Air, H19, IPW, and ncr-UPAR) are consistently upregulated. The expression of SAF and Zeb2Nat, two lncRNAs implicated in oncogenesis, exhibited the highest fold change, thus suggesting that SAF and Zeb2Nat are instrumental in the pathogenesis of alcohol-induced oropharyngeal cancers. The stem cell genes Nanog and Oct-4, and the epithelial-to-mesenchymal transition (EMT) gene Vimentin, were also upregulated through ethanol treatment, thereby suggesting that ethanol could promote expression of the EMT phenotype and stemness in vivo. Conclusions: Ethanol exposure in normal oral epithelia dysregulates key lncRNAs previously implicated in cancer, and induces stem cell and EMT genes. Further investigation of the pathways of these lncRNAs may lead to prognostic indicators and therapeutic targets in treatment of alcohol-induced oropharyngeal cancers. 
Background:
We have previously demonstrated that reduced CXCR4 expression is associated with a lymphoplasmacytoid immunophenotype and extramedullary disease in a mouse model of plasma cell myeloma (PCM). We and others have also shown that reduced CXCR4 is associated with poor survival in PCM patients, especially those treated with bortezomib. In this study we sought to optimize CXCR4 immunohistochemical staining of plasma cells in formalin fi xed trephine core biopsies. In addition, we examined the association of CXCR4 expression with the cytogenetic and morphologic subtypes of PCM. We hypothesized that cases with a t(11;14) were more likely to have decreased/absent CXCR4 expression. Design: We queried our cytogenetics database and identifi ed 40 cases of PCM (including 24 diagnostic specimens) that harbored the most common recurrent cytogenetic abnormalities. We then reviewed bone marrow biopsies/smears and clinical data corresponding to the same accession dates. In addition, immunohistochemical (IHC) studies were performed on the core biopsies including CD20 and CXCR4. Stain intensity was scored from 0 (negative) to 3 (strongly positive). Statistical analysis was performed using Fisher's exact tests. Results: 35% of PCM cases (14/40) were positive for surface expression of CXCR4, while nearly all control plasma cells were positive. Similar to previous studies, CD20 positivity was associated with the presence of t(11;14) (P < 0.001, Fisher's), but was not associated with strong or absent CXCR4 expression. Among the cases that bore a t(4;14) or t(14;16), all lacked CXCR4 expression (P = 0.035, Fisher's). In addition, among all cytogenetic abnormalities, cases without hyperdiploidy were more likely to lack CXCR4 (P =.041, Fisher's). Conclusions: Our previous studies have demonstrated that bortezomib resistant PCM cells are more likely to have an immunophenotype intermediate between lymphocytes and plasma cells, including decreased CXCR4. We also have shown that reduced CXCR4 expression confers a worse prognosis in PCM patients. Our data confi rm that PCM cells harboring a t(11;14) are more likely to express CD20 but do not appear to have
